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Enzymes are macromolecular machines in the cells that catalyze the chemistry 
of life.  Structural and biochemical studies of enzymes and its ligands shed lights on 
the catalytic mechanism and guide efforts of rational drug design.  In this work, three-
dimensional structures and biochemical analysis are presented to expand our 
understanding of two independent enzymes, pseudouridine monophosphate (ΨMP) 
glycosidase and thiamine pyrimidine synthase.   
Pseudouridine (Ψ), the C-isomer of uridine, is the most abundant modified 
nucleotide in nature.  Despite extensive mechanistic study of Ψ biosynthesis, the 
degradation pathway for Ψ has not been discovered until recently.  In this pathway, Ψ 
is first phosphorylated by Ψ kinase and then degraded into uracil and ribose 5-
phosphate by ΨMP glycosidase.  Here we present crystallographic and biochemical 
study of ΨMP glycosidase.  Four unique structures of ΨMP glycosidase were 
displayed to illustrate the reaction pathway of ΨMP degradation.  The combination of 
structural and biochemical study elucidates the mechanism of Ψ degradation and 
stands as the first example of the mechanistic study of the unusual C-C glycosidic 
bond cleavage.   
 Thiamin pyrophosphate is the active form of vitamin B1 and an essential 
cofactor for all living systems.  The synthesis of thiamin pyrophosphate involves 
coupling of the thiazole and pyrimidine moieties, which are synthesized separately.  
All enzymes in prokaryotes and eukaryotes involved in the thiamin biosynthesis 
pathway have been structurally characterized, except the eukaryotic thiamin 
pyrimidine synthase THI5p.  THI5p synthesizes the pyrimidine moiety of thiamin 
from histidine and pyridoxal phosphate.  This study suggested that THI5p served as 
the histidine source and became inactive after a single turnover.  Moreover, crystal 
structure of THI5p revealed the identity of the histidine residue and the spatial 
relationship between the imidazole and the pyridoxal ring.  As the reaction also 
required iron and oxygen, a starting mechanism was proposed, involving Diels-Alder 
reaction followed by iron-mediated oxidation.  Additional structural evidence showed 
oxidative modification of a cysteine residue at the potential iron binding site, in THI5p 
after the reaction.  The irreversible modification of the cysteine thiol provided further 
insights into the remarkable chemistry of this suicide enzyme. 
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CHAPTER 1 
INTRODUCTION 
Section 1.1. Overview of Structural Biology  
Proteins are a diverse and abundant family of biopolymers.  Comprising about 
50% of a cell's dry weight, proteins are major players in almost every essential process 
of life, including serving as basic building blocks, catalyzing a multitude of 
biochemical reactions, and maintaining a stable cellular environment.  The basic 
monomer of a protein is the amino acid.  The primary structure of protein is simply the 
arrangement of amino acids in a single polypeptide chain.  Interactions between 
adjacent amino acids reshape the polypeptide chain into secondary structures such as 
helical or pleated segments.  The secondary structures of proteins further fold into 
globular tertiary structures.  Some proteins contain multiple polypeptides with 
characteristic tertiary structures.  The organization of tertiary structures constitutes the 
quaternary structure of proteins.   
Recent developments in structural biology based on the characterization of 
protein structures have tremendously contributed to the understanding of the complex 
biological system that governs cellular function.  By virtue of the availability of multi-
wavelength synchrotron sources (1), high-resolution crystal structure determination 
became possible and vast majority of protein structures are determined using X-ray 
crystallography in the past decade.  The advances of computer science and physics 
also considerably accelerated the process of structure determination.  Coupled with 
kinetic characterization, site-directed mutagenesis, mass spectrometry analysis and 
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various spectroscopic methods, crystallography has become a powerful tool to study 
the protein structure-function relationship.    
One of the major goals of structural biology is to understand the catalytic 
mechanisms of enzymes that are important to the cellular processes.   As many 
enzymes are potential drug targets, the elucidation of the mechanistic details of the 
enzyme can provide valuable information for the rational design of drugs (2).  X-ray 
crystallography has been a powerful tool in both the de novo design and lead 
optimization in drug development.  For example, the development of the drug 
Agenerase® (3) against HIV protease and Thymitaq® (4) for the liver cancer 
treatment are classic examples of structure-based drug design.  The 2012 Nobel Prize 
in Chemistry was awarded to Dr. Robert Lefkowitz and Dr. Brian Kobilka for their 
structural and functional studies on G-protein coupled receptors, which are responsible 
for the majority of transmembrane signal transduction and the are target of about 30% 
of all drugs (5).   
Once a drug target has been revealed and elucidated with a structure, leads can 
be either designed de novo or identified through database search.  If the synthesis is 
feasible, a small library of compounds similar to the proposed ligand will be 
chemically synthesized.   Then the compound can be tested in a biochemical or cell-
based assay to determine if the design is successful.  The initial structure 
determination of the drug target, the design of the lead, the chemical synthesis of the 
lead and the series of biological assays constitute a typical cycle of drug design.  It is 
often necessary to go through several cycles of lead optimization before a drug 
candidate emerges (3).   
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Section 1.2. Pseudouridine Degradation 
Among the many dynamic research in the RNA world, a large number of 
structurally diverse modifications on the polyribonucleotides have be identified and 
become an active field of research in the past several years.  Pseudouridine (Ψ), the C-
glycoside isomer of uridine, is not only the first modified nucleotide to be identified, 
but also the most abundant RNA modification in nature, thus is often termed as the 
"fifth nucleoside" (6).  Ψ ubiquitously exists in rRNA, tRNA, snRNA and snoRNA 
and is formed through site-specific post-transcriptional modification of uridine (7).  
The binding of uracil to ribose through C5 rather than N1 exposes an additional N-
bound hydrogen that enables a structured water molecule to coordinate both Ψ and the 
sugar-phosphate.  This rigidifying effect stabilizes the phosphodiester bonds in 
vicinity (8-10), and thereby enhances the stacking of neighboring nucleosides.  The 
stabilizing effect underlies most of the biological functions of Ψ 
residue in RNA.  For example, Ψ is not only found as the nearly universal Ψ55 in the 
TΨC stem in tRNAs, but also frequently exists in the D stem and the anticodon stem 
and loop (11-13).  In tRNAs, during translation, Ψ may be involved in modulating the 
interactions that tRNA molecules makes with rRNAs and with mRNAs by affecting 
the local structure of neighboring domains (14).  Pseudouridylation is also found to 
play an important role in influencing the decoding activity of tRNAs and improving 
the fidelity of protein biosynthesis (15).  In rRNAs, Ψ is believed to involve both 
rRNA folding and ribosome assembly (16), which can be attributed to the structural 
stability afforded by Ψ.  In the mature ribosome, Ψ may contribute to stabilizing local 
structures through RNA-RNA and RNA-protein interactions (17).   
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Since the Ψ level increases in tumor bearing patients (18, 19), the biosynthesis 
of Ψ has drawn considerable attention in the past few years.  A combination of 
biochemical, biophysical and structural study has been carried out to elucidate the 
mechanism for Ψ biosynthesis.  Studies showed that the biosynthesis of Ψ is carried 
out by Ψ synthase through a site-specific modification from uridine to Ψ in RNA 
(20).  Ψ synthase acts on the maturing RNAs by severing the C-N glycosidic bond, 
flipping the base along the N3-C6 axis and reattaching the uracil to the ribose through 
a C-C glycosidic bond (9).  The C-C glycosidic bond is unusual in nature.  Little was 
known about the degradation pathway of Ψ and the cleavage of C-C glycosidic bond 
until the recent discovery of two genes that encode two enzymes that catalyze the 
degradation of Ψ (21).  Ψ kinase and ΨMP glycosidase are associated in the same 
operon in bacteria and exist as a homologous bifunctional protein in lower eukaryotes.  
Human beings do not have the gene that encodes the bifunctional enzyme, and 
therefore are unable to utilize Ψ.  In the Ψ degradation pathway, Ψ is first converted to 
pseudouridine 5´-monophosphate (ΨMP) by Ψ kinase and then ΨMP is degraded by 
ΨMP glycosidase to uracil and ribose 5-phosphate (Figure 1.1).  ΨMP glycosidase is 
the first example of a mechanistically and structurally characterized enzyme that 
cleaves a C-C glycosidic bond (22).  While O-C and N-C glycosidic bond are 
prevalent in nature and the mechanisms for cleavage have been extensively studied 
(23-26), the mechanism for C-C glycosidic bond remains unknown.  Compared to O-
N and C-N glycosidic bond, C-C glycosidic bond is much more stable 
thermodynamically and resistant towards hydrolysis.  Chapter 2 outlines the structural 
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and biochemical characterizations of Escherichia coli ΨMP glycosidase.  A series of 
crystal structures of enzyme-substrate and enzyme-intermediate complexes have been 
determined.  Four unique snapshots are displayed along the reaction coordinate, thus 
revealing the unprecedented chemistry and expanding our knowledge in glycosidic 
bond cleavage. 
 
Figure 1.1. Reaction catalyzed by Ψ kinase and ΨMP glycosidase. 
Section 1.3. Vitamin B1 Biosynthesis 
Vitamin B1 is an essential cofactor in all living systems and involved in amino 
acid synthesis and carbohydrate metabolism (27).  Vitamin B1 is found in high 
concentration in brain, heart, skeletal muscle, kidney and liver in human beings.  The 
deficiency of vitamin B1 can cause fatal disease such as neurological disorder and 
cardiac disorder, especially for alcoholics (28).  Bacteria and archea, as well as low 
eukaryotes, synthesize thiamine, whereas higher eukaryotes like human beings cannot 
produce thiamin and require it as dietary supplement.  Deficiency in vitamin B1 in 
humans causes both cardiovascular system disorder (29) and brain disorder (28). The 
transport form of vitamin B1 is thiamin, while the active form is thiamin 
pyrophosphate.  Thiamin pyrophosphate consists of thiazole and pyrimidine moieties, 
which are biosynthesized separately in both prokaryotes and eukaryotes (Figure 1.2)  
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Figure 1.2.  Thiamin pyrophosphate biosynthetic pathway in Saccharomyces 
cerevisiae. 
 
and then coupled (30).  In eukaryotes, thiamine pyrimidine is biosynthesized from 
histidine and pyridoxal 5´-phosphate (PLP) and utilizes the enzyme THI5p (31-34).  
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of the Candida albicans pyrimidine synthase (THI5p).  A structure of the C. albicans 
THI5p shows a PLP bound in the active site via an imine with Lys62 and His66 is in 
close proximity to the PLP.  The biochemical assay and the crystal structure suggest 
that His66 is the histidine source for pyrimidine formation and that the pyrimidine 
synthase is a suicide enzyme that becomes inactive after a single-turnover.  Chapter 4 
provides further insights into THI5p as a suicide enzyme by determination of the 
crystal structure of a modified THI5p that undergoes irreversible trioxidation on a 
cysteine residue at the active site.  A series of conformational changes have been 
observed with local movements in the small domain of the enzyme.  The crystal 
structures of C199A/PLP complex and the C-terminus truncated mutant E309Ter/PLP 
complex are also determined to reveal the structural evidence of the flexible C-
terminus.  Along with the support from the LC-MS data, the four structures 
demonstrate the unique chemistry of this single-turnover enzyme and unveil the 
remarkable reaction that is without chemical and biochemical precedent. 
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CHAPTER 2 
PSEUDORURIDINE MONOPHOSPHATE GLYCOSIDASE:  
A NEW GLYCOSIDASE MECHANISM1 
Section 2.1. Introduction 
Pseudouridine (Ψ) was the first modified nucleoside to be discovered and is the 
most abundant modification in RNA, existing in tRNAs, rRNAs, snRNAs and 
snoRNAs (1).  Ψ is biosynthesized post-transcriptionally from RNA uridine moieties 
by Ψ synthase, which cleaves the glycosidic C-N bond and reconnects the uracil to the 
ribosyl moiety at the C5 position (2).  Pseudouridine reduces the conformational 
flexibility of RNA because the exposed, protonated N1 atom forms strong hydrogen 
bond with a structured water molecule, replacing weak interactions formed by C5 (1, 
3). 
 While Ψ biosynthesis has been studied extensively, little is known about Ψ 
catabolism.  Recently, the two enzymes responsible for Ψ 1 degradation in 
Escherichia coli were identified (4).  Ψ kinase first phosphorylates Ψ to pseudouridine 
5´-phosphate (ΨMP, 2).  ΨMP glycosidase then catalyzes the reversible cleavage of 
the C-C glycosidic bond to form uracil 4 and ribose 5-phosphate (R5P, 3) (Figure 2.1).   
 
 
Figure 2.1. Reactions catalyzed by Ψ kinase and ΨMP glycosidase. 
                                                
1 Produced with permission from Huang S., Mahanta N., Begley T. P., Ealick S. E., 
(2012), Biochemistry.  Copyright © 2012 American Chemical Society 
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While ΨMP glycosidase functions biologically in the cleavage direction, 
equilibrium strongly favors ΨMP synthesis with an equilibrium constant for the 
degradation reaction of 2.3 × 10-4 M (4).  In bacterial genomes Ψ kinase and ΨMP 
glycosidase are encoded by separate genes.  In E. coli these genes are yeiC and yeiN, 
respectively, which are located in the same operon.  In some eukaryotes, the genes for 
Ψ kinase and ΨMP glycosidase are fused, resulting in a bifunctional enzyme.  
Enzymes metabolizing Ψ are not found in humans and most other higher organisms, 
and excess Ψ is excreted (5). 
While natural products containing O and N glycosidic bonds are widespread, 
natural products containing the C-glycosidic bond are much less prevalent (6). The C-
glycosidic bond is generally assumed to be formed by an electrophilic aromatic 
substitution.  Enzymes that cleave C-N glycosidic bonds have been extensively 
studied.  These include nucleoside and nucleotide hydrolases (7-9), purine and 
pyrimidine nucleoside phosphorylases (10), purine and pyrimidine 
phosphoribosyltransferases (11, 12), and nucleoside deoxyribosyltransferases (13).  In 
addition, DNA-repair enzymes such as endonuclease III function as N-glycosylases to 
excise damaged nucleobases from DNA (14).  Enzymes that cleave C-O glycosidic 
bonds are widespread in carbohydrate metabolism and have also been extensively 
studied (15). Biochemical, biophysical and genetic studies suggest that these enzymes 
cleave C-N and C-O glycosidic bonds by a largely dissociative mechanism generating 
an oxocarbenium ion intermediate.  While the genes encoding several C-
glycosynthases have been identified and in many cases overexpressed (16-23) and the 
structures of ligand free UrdGT2 (24, 25) and ΨMP glycosidase (26) have been 
determined – there is currently no example of a mechanistically well-characterized C-
glycosidase or glycosynthase.  
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 Here we report a set of E. coli ΨMP glycosidase (EcΨMP glycosidase) crystal 
structures, which provide four snapshots of the reaction coordinate.   The structures 
are: the unliganded enzyme, a ΨMP glycosidase/ring-opened R5P adduct, a ΨMP 
glycosidase/ ring-opened ribose ΨMP adduct, and a K166A ΨMP complex. The 
structural studies suggested that the reaction involves an intermediate imine with 
Lys166. This was confirmed by mass spectrometry.  Kinetic studies on active site 
mutants suggested roles for individual amino acid side chains.  Comparison of the 
EcΨMP glycosidase structures suggested a role for conformational changes in ΨMP 
cleavage and product release.  These results suggest an unanticipated mechanism for 
the ΨMP glycosidase catalyzed C-glycosyl bond hydrolysis. 
Section 2.2. Materials and Methods 
Cloning, Overexpression and Purification of ΨMP Glycosidase.  Standard 
methods were used for DNA restriction endonuclease digestion, ligation and 
transformation of DNA (27).  Automated DNA sequencing was performed at the 
Cornell BioResource Center.  Plasmid DNA was purified with a GeneJet miniprep kit 
(Fermentas, Glen Burnei, MD).  DNA fragments were separated by agarose gel 
electrophoresis, excised and purified with the Zymoclean gel DNA recovery kit 
(Zymo Research, Orange, CA).  E. coli strain MachI (Invitrogen, Madison, WI) was 
used as the recipient for transformations during plasmid construction and for plasmid 
propagation and storage.  An Eppendorf Mastercycler and Phusion DNA polymerase 
(New England Biolabs, Ipswich, MA) were used for PCR.  All restriction 
endonucleases and T4 DNA ligase were purchased from New England Biolabs 
(Ipswich, MA).  E. coli strain BL21(DE3) and the pET overexpression system were 
purchased from Novagen (Madison, WI).   
The yeiN gene was PCR amplified from E. coli K12 genomic DNA using the 
following primers: upstream primer 5´-GGG TAG CAT ATG TCT GAA TTA AAA 
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ATT TCC CCT G-3´ (inserts an NdeI site at the start codon of the yeiN open reading 
frame); downstream primer 5´-CCC TAC TCG AGT TAA CCC GCG AGA CGC 
TGA TAT TC-3´ (inserts an XhoI site after the end of the yeiN open reading frame).  
The purified PCR product was digested with NdeI and XhoI, purified and ligated into 
similarly digested pTHT, a pET-28 derived vector, which allows attachment of a 
modified six histidine tag followed by a tobacco etch virus protease cleavage site onto 
the N-terminus of the expressed protein.  Colonies were screened for the presence of 
the insert and a representative plasmid was designated pEcYeiN.THT.  The PCR-
derived DNA was sequenced and shown to contain no errors. 
The yeiN gene was further transformed into E. coli strain BL21(DE3) 
(Novagen).  The cells were grown overnight in a 10 mL starter culture in Luria-
Bertani (LB) media (28) containing 30 µg/mL kanamycin, then transferred to cultures 
containing 1.5 L LB media and incubated at 37 ºC with shaking until an OD600 of 0.8 
was achieved.  The culture was then induced with 1 mM isopropyl-1-β-D-
galactopyranoside and incubated overnight at 15 ºC.  Cells were harvested by 
centrifugation at 10000 g for 30 min at 4 ºC and resuspended in a lysis buffer 
containing 50 mM tris(hydroxymethyl)aminomethane (Tris), pH 8.0, 300 mM NaCl, 
10 mM imidazole, and lysed by sonication.  The lysate was centrifuged at 40000 g for 
30 min and the supernatant was loaded onto a column containing 2 mL Ni-NTA resin 
(Qiagen) preequiliburated with the lysis buffer.  The column was then washed with 
three times the volume of wash buffer containing 50 mM Tris, pH 8.0, 300 mM NaCl 
and 30 mM imidazole for 1.5 h.  The protein was eluted with 50 mM Tris, pH 8.0, 300 
mM NaCl, and 250 mM imidazole.  The eluted protein was then subjected to size 
exclusion chromatography using an ACTA Explorer FPLC with a HiLoad 26/60 
Superdex 200 prep grade column (GE Healthcare).  The resulting protein was more 
than 95% pure as judged by SDS-PAGE analysis (unpublished experiments).  The 
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protein was then concentrated to 15 mg/mL using an Amicon concentrator (30 kDa 
MWCO filter, Millipore), flash frozen and stored at -80 ºC. 
ΨMP Glycosidase Mutagenesis.  Site directed mutagenesis was performed by a 
standard PCR protocol using PfuUltraII DNA polymerase per the manufacturer’s 
instructions (Agilent) and DpnI to digest the methylated parental DNA prior to 
transformation.  In addition to the forward and reverse primers required to introduce 
the mutation, a third primer was designed to screen for the presence of the mutation by 
colony PCR (Table 2.1).  For screening, the primers designated “sF” were paired with 
the T7T primer (5´-GCTAGTTATTGCTCAGCGG-3´) and the primers designated 
“sR” were screened with the T7Plac primer (5´-TATAGGGGAATTGTGAGCGG-3´).  
All the mutants were verified by sequencing. 
Enzymatic Synthesis of ΨMP.  2.5 mg ΨMP glycosidase, 100 mM uracil and 
R5P were incubated in a buffer containing 0.5 mM MnCl2, 25 mM HEPES, pH 7.1 at 
25 °C for 1 h.  The enzyme was removed using an Amicon 30 kDa MWCO 
(Millipore) filter.  The reaction product was identified as ΨMP by comigration with an 
authentic sample of ΨMP during HPLC analysis . 
Crystallization of ΨMP Glycosidase.  ΨMP glycosidase was crystallized using 
the hanging drop vapor diffusion method at 22 ºC.  The initial crystallization condition 
was determined using sparse matrix screens Crystal Screen 1 and 2 (Hampton 
Research).  The optimized reservoir conditions were 20% polyethylene glycol 4000, 
0.2 M sodium acetate and 0.1 M Tris, pH 7.0.  ΨMP glycosidase was incubated with 4 
mM MnSO4 before crystallization.  The drops contained 1.5 µL of protein solution and 
1.5 µL of reservoir solution.  Prismatic crystals grew within 2 d to the size of 200 µm 
× 50 µm × 50 µm.   
The ΨMP glycosidase/R5P complex was co-crystallized under similar 
conditions except that the protein was incubated with 4 mM MnCl2 and 2 mM R5P for  
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Table 2.1.  Primer sequences of ΨMP glycosidase and the mutants.  In addition to the 
forward and reverse primers required to introduce the mutation, a third primer was 
designed to screen for the presence of the mutation by colony PCR.   The primers 
designnated “sF” were paired with the T7T primer (5’-
GCTAGTTATTGCTCAGCGG-3’) and the primers designated “sR” were screened 
with the T7Plac primer (5’-TATAGGGGAATTGTGAGCGG-3’).   
 
Mutant Primer Sequences* 
D149A D149A-F ccttcgatatttctgccgCGttgcaagaactggcaaatac 
D149A-R gtatttgccagttcttgcaaCGcggcagaaatatcgaagg 
D149A-sF ccttcgatatttctgccgCG 
E31A E31A-F caaaaaaccggttgtggcgctggCGtcgaccattatttctcac 
E31A-R gtgagaaataatggtcgaCGccagcgccacaaccggttttttg 
E31A-sF aaccggttgtggcgctggCG 
E31L E31L-F caaaaaaccggttgtggcgctgCTGtcgaccattatttctcac 
E31L-R gtgagaaataatggtcgaCAGcagcgccacaaccggttttttg 
E31L-sF aaccggttgtggcgctgCTG 
K93A K93A-F cgtgaagggcataacgtgaccGCGgttagtcgtcgcgatttacc 
K93A-R ggtaaatcgcgacgactaacCGCggtcacgttatgcccttcacg 
K93A-sF aagggcataacgtgaccGCG 
K93E K93E-F cgtgaagggcataacgtgaccGaGgttagtcgtcgcgatttacc 
K93E-R ggtaaatcgcgacgactaacCtCggtcacgttatgcccttcacg 
K93E-sF aagggcataacgtgaccGaG 
K166A K166A-F ccgttgtttgtgccggggcgGCGtctattctcgatttagg 
K166A-R cctaaatcgagaatagaCGCcgccccggcacaaacaacgg 
K166A-sF ttgtttgtgccggggcgGCG 
H137A H137A-F ccgggggaattggtggtgtgGCGcgcggggcggaacataccttcg 
H137A-R cgaaggtatgttccgccccgcgCGCcacaccaccaattcccccgg 
H147A-sF ggggaattggtggtgtgGCG 
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30 min prior to crystallization.  The ΨMP glycosidase/ ring-opened ribose ΨMP 
complex was obtained by co-crystallizing ΨMP glycosidase with 4 mM MnCl2, 2 mM 
R5P and saturated uracil.  The K166A/ΨMP complex was prepared by cocrystallizing 
the mutant enzyme with R5P and uracil. 
 Data Collection and Processing.  Prior to the data collection, crystals were 
soaked in a cryoprotectant solution of 5% glycerol in the mother liquor to avoid 
damage during vitrification.  Data sets for ΨMP glycosidase and the complexes were 
collected at the Northeast Collaborative Access Team (NE-CAT) beamline 24-ID-C at 
the Advanced Photon Source (APS) using an ADSC Quantum 315 detector (Area 
Detector Systems Corporation) at a wavelength of 0.9795 Å with 1 s exposure times 
and 1° oscillation angles.  The data set for the K166A/ΨMP complex was collected at 
Cornell High Energy Synchrotron Source (CHESS) using an ADSC Quantum 270 
detector at a wavelength of 0.9180 Å with 1 s exposure times and 1° oscillation 
angles.  The detector distances were 275, 350, 325 and 200 cm for the ΨMP 
glycosidase, the R5P complex, the ring-opened ribose ΨMP complex and the K166A--
ΨMP complex, respectively. the HKL2000 program suite (29).  Data collection 
statistics are summarized in Table 2.2.  
Structure Determination and Refinement.  The structure of EcΨMP 
glycosidase was determined by molecular replacement using MOLREP (30),  The 
search model was a monomer of PDB ID 1VKM, which has 39% sequence identity to 
ΨMP glycosidase, after modification by CHAINSAW (31).  1VKM was originally 
reported to be an indigoidine (IndA)-like protein from Thermotoga maritima (26), but 
later shown to be a ΨMP glycosidase (4).  The model was refined through successive 
rounds of manual model building using COOT (32) and restrained refinement with 
REFMAC5 (33).  Water molecules were then included after the model converged, 
followed by two additional rounds of refinement.  The structure of the ΨMP 
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glycosidase/ring-opened R5P adduct was determined by using the structure of 
unliganded ΨMP glycosidase as the model and refining with REFMAC5 (33).  The 
structure of the ΨMP glycosidase/ ring-opened ribose ΨMP adduct, which crystallized 
in a different space group, was determined by molecular replacement using MOLREP 
(30) using a monomer from the refined ΨMP glycosidase as the search model.  The 
structure of the K166A/ΨMP complex was determined by using the structure of the 
ΨMP glycosidase/ ring-opened ribose ΨMP adduct as the model and refining with 
REFMAC5 (33).  The ligand contents and alternative side chain conformations were 
determined by Fo-Fc maps and composite omit maps from PHENIX (34).  All ligands 
were clearly observed in the composite omit map, but were not placed until the last 
stage of the refinement.  The data collection and refinement statistics are summarized 
in Table 2.3. 
HLPC Analysis of the Reaction Mixture.  HPLC analysis following a linear 
gradient, at a flow rate of 1 mL/min, was used with absorbance detection at 254 nm.  
Solvent A was water, solvent B was 100 mM K2HPO4, pH 6.6 and solvent C was 
methanol: 0 min, 100% B; 5 min, 10% A, 90% B; 7 min, 25% A, 60% B, 15% C; 17 
min, 25% A, 60% B, 15% C; 19 min, 30% A, 40% B, 30% C; 21 min, 100% B; 30 
min 100% B.  The column used was a Supelcosil LC-18- T HPLC column (15 cm x 
4.6 mm, 3 µM particle size). 
Time Course for the Reverse ΨMP Glycosidase Reaction.  The reaction 
mixture contained 20 µM uracil, R5P, and 250 µM MnCl2. The reaction mixture was 
divided into 90 µL aliquots and 10 µL of 10 µM ΨMP glycosidase was added to 
achieve a final concentration of 1 µM ΨMP glycosidase. The reaction was quenched 
at 20 s, 40 s, 1 min, 2 min, and 5 min by heating it at 100 °C for 2 min. The samples 
were filtered (10 kDa MWCO) and analyzed by RP-HPLC using the method described 
above.  The peak areas for ΨMP were integrated and plotted against time. 
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Table 2.2. Data collection statistics 
 
ΨMP 
glycosidase 
ΨMP 
glycosidase/ 
ring-opened R5P 
ΨMP glycosidase 
/ring-opened 
ribose ΨMP 
K166A/ΨMP 
beamline APS 24-ID-C  APS 24-ID-C  APS 24-ID-C CHESS F1  
wavelength (Å) 0.9792  0.9795  0.9795 0.9180  
space group P212121  P212121  P212121 P212121  
a (Å)  62.1  61.3  61.5 60.7  
b (Å)  115.4  116.5  77.1 76.4  
c (Å)  132.0  132.2  200.0 199.0  
chains per 
asymmetric unit  
3 3 3 3 
resolution (Å) 43.5-2.0 
(1.94-1.96)a 
41.2-2.2 
(2.19-2.32) 
48.1-2.5 
(2.50-2.57) 
35.3-1.8 
(1.80-1.82)  
total no. of 
reflections 
404,995  196,780  124,598 422,749  
 
number of unique 
reflections 
70,995  49,316  33,815 86,433  
 
redundancy 5.7 (5.5)a 4.0 (4.0)  3.7 (3.4) 4.9 (4.9)  
Rmerge (%)b 5.5 (34.3)a  6.0 (40.9)  7.5 (44.1) 7.3(43.1)  
completeness (%) 99.7 (99.6)a  99.8 (99.9)  99.1 (96.9) 99.1(100)  
I/σ(I) 25.1 (4.2)a  17.6 (2.4)  17.5 (3.1) 20.4 (3.6)  
aValues in parentheses are for the highest resolution shell. 
bRmerge = ΣΣi | Ii − <Ι> | / Σ <Ι>, where <Ι> is the mean intensity of the N reflections 
with intensities Ii and common indices h,k,l. 
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Table 2.3. Data refinement statistics 
 
ΨMP 
glycosidase 
ΨMP 
glycosidase/ 
ring-opened R5P 
ΨMP glycosidase 
/ring-opened 
ribose ΨMP 
K166A/ΨMP 
no. of reflections 
in working set 
66,972  45,946  31,542 81,618  
Rwork/ Rfreea (%) 18.5/22.0 17.9/23.1 18.5/26.1 17.7/20.7 
no. of protein 
atoms 
6,423 6,533 6,399 6,575 
no. of ligand 
atoms 
18  69  93 66  
no. of water 
atoms 
375 328 210 644 
average B-factor 
protein (Å2) 
35.0 41.4 53.5 27.3 
average B-factor 
water (Å2) 
34.1 37.3 39.9 31.3 
average B-factor 
ligand (Å2) 
57.7 39.5 49.5 17.6 
rmsd for bonds 
(Å) 
0.008 0.007 0.008 0.007 
rmsd for angles 
(°) 
1.2 1.2 1.3 1.2 
aR = Σhkl| |Fobs| − k |Fcal| | / Σhkl |Fobs| where Fobs and Fcal are observed and calculated 
structure factors. Rwork = is calculated over all reflections used in the refinement.  Rfree 
is calculated over a subset of reflections (5%) excluded from all stages of refinement. 
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For the K166A mutant, the reaction mixture (1 mL) contained 500 µM each of 
uracil, R5P, and 250 µM of MnCl2.  The reaction mixture was divided into 90 µL  
aliquots and 10 µL of 200 µM K166A was added to achieve the final concentration of 
K166A (20 µM). The reaction was quenched at 20 s, 40 s, 1 min, 2 min, 3 min, 5 min, 
10 min and 20 min time points by heating each reaction mixture at 100 °C for 2 min.  
The reaction samples were filtered (10 kDa MWCO) and analyzed by RP-HPLC. The 
peak area for ΨMP was integrated and plotted against time. 
Determination of kcat and Km for the Reverse ΨMP Glycosidase Reaction.  
Uracil concentrations were varied while keeping the R5P concentration at saturation (1 
mM) and the MnCl2 concentration at 250 µM. ΨMP formation was monitored by 
HPLC analysis.  Each reaction mixture was divided into 90 µL aliquots and 10 µL of 
10 µM ΨMP glycosidase was added to achieve the final concentration of 1 µM.  For 
each set of reactions, the reaction was quenched at 20 s, 40 s, 1 min, 2 min, 3 min, 5 
min, and 10 min time points by heating at 100 °C for 2 min.  In the case of K166A, the 
uracil concentrations were varied while keeping R5P concentration at 1 mM and 
MnCl2 concentration at 250 µM for five different sets of reactions.  Each reaction 
mixture was divided into 85 µL aliquots and 15 µL of 250 µM K166A was added to 
start the reaction (final concentration 37.5 µM).  For each set of reactions, the reaction 
was quenched at 20 s, 40 s, 1 min, 2 min, 3 min, 5 min, and 10 min time points by 
heating at 100 °C for 2 min.  All samples were analyzed by HPLC and the amount of 
ΨMP formed was plotted against time for each set of substrate concentrations.  The 
initial slopes from each set of reactions were then plotted against the substrate 
concentration and fit to the Michaelis-Menten equation using KaleidaGraph (Synergy 
Software). The mutant E31A, K93A, H137A, D149A, and N289A activities were 
measured using a similar procedure. 
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Biochemical Characterization of the ΨMP Glycosidase R5P Adduct.  A 
reaction mixture containing 2 mM R5P and 1 mM Mn in 50 mM Tris-HCl, 100 mM 
NaCl and 2 mM TCEP (pH 8.0) was incubated at room temperature for 1 h with ΨMP 
glycosidase (50 µM), followed by addition of sodium borohydride (2 mg) and further 
incubation at room temperature for 45 min.  The sample was then buffer-exchanged 
into 10 mM ammonium acetate (pH 8.0) using a Bio-Rad desalting column and 
analyzed by ICR-MS. Control samples, one containing 2 mM uracil and the other 
lacking R5P and MnCl2 were similarly prepared and analyzed.  
To locate the site of adduct formation, trypsin digestion analysis was 
performed on each of these samples as follows: 10 µL of guanidine-HCl (6 M) was 
added to each sample (50 µL containing 100 µg of ѰMP glycosidase), followed by 1 
µL of  DTT (200 mM). After a 1 h incubation at room temperature, 10 µL of 
iodoacetamide (200 mM) was added and the reaction mixture was further incubated in 
the dark for 1 h.  29 µL of ammonium bicarbonate buffer were further added to reduce 
the final concentration of guanidine-HCl to 0.6 M (final volume 100 µL). 1 µL of 
trypsin in 50 mM ammonium bicarbonate buffer, pH 8.0 (1 µg/ µL) was added and the 
samples were incubated at 37 ºC for 20 h. The samples were then analyzed by LC-MS. 
Circular Dichroism Measurements. The ΨMP glycosidase protein was in 
the buffer of 10 mM Tris, 100 mM NaCl, pH 8.0, and used at a final concentration of 
7 μM.  Data was collected for both the wild-type enzyme and the D149A mutant, 
either with or without the addition of 300 μM MnCl2.  The spectra were collected 
using an AVIV Biomedical (Lakewood, NJ) Circular Dichroism Spectrometer, Model 
202-01.  The data were collected at 22 °C from 200 to 250 nm with a 1-nm step size, a 
1-nm bandwidth and 1mm-cell length.  The spectra represented the average of 10 
replica scans.  Program K2D2 was used to deconvolute secondary structure contents. 
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Section 2.3. Results 
Overall Structure of ΨMP Glycosidase.  ΨMP glycosidase is a homotrimer 
(Figure 2.2A) with one trimer per asymmetric unit in the crystal structure.  Of the 312 
possible residues, each protomer is complete except for the first two to five residues at 
the N-terminus and the C-terminal residue, which is missing in most of the protomers.  
ΨMP glycosidase shows an αβα fold.  The central mixed β-sheet contains 11 strands 
with topology 1↑4↑3↓2↓7↓8↓11↓9↓10↓5↑6↑ and is flanked by six α-helices on one 
side and seven α-helices on the other (Figure 2.2 B, C).  The structure of the protomer 
is similar to that of PDB ID 1VKM (26), which was used as a search model during 
molecular replacement. The trimer contains a buried surface area of 8650 Å2, 
accounting for 27.8 % of the total surface area.  The trimer interface is mainly formed 
by helices α5 and α8 from one protomer and helices α9 and α10 from the adjacent 
protomer.  The interface includes hydrogen bonds between Ile146-Thr180* (* 
indicates residues from an adjacent protomer) and Arg96-Asn228*, and a salt bridge 
between Arg97 and Glu179*. 
Mn(II) Binding Site. Mn(II) is required for ΨMP glycosidase activity (4) and 
for the formation of high quality crystals.  The Mn(II) coordination is octahedral with 
Mn(II) to oxygen distances ranging from 2.13 Å to 2.35 Å (Figure 2.3).  Only one 
protein residue, Asp145, participates in coordination and water molecules (W1-W5) 
occupy the remaining five positions. The coordinating oxygen atoms interact with 
protein atoms, substrate atoms (see below), and other water molecules.   W1 hydrogen 
bonds to Glu179* and a ΨMP phosphate oxygen atom, W2 hydrogen bonds to His137 
and a ΨMP phosphate oxygen atom, W3 hydrogen bonds to Asp145, the carbonyl 
oxygen atom of Gly266, W4 hydrogen bonds to Glu176* and Glu179*, W5 hydrogen 
bonds to a water molecule in the second sphere (W11) and a water molecule (W7) that 
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Figure 2.2.  Structure of ΨMP glycosidase.  (A) Ribbon diagram of the ΨMP 
glycosidase trimer color coded by protomer.  The active site is indicated by the space 
filling model.  The Mn(II) ion is shown in purple.  (B) Ribbon diagram of a ΨMP 
glycosidase protomer labeled with color coded α-helices (blue) and β-strands (35).  (C) 
Topology diagram of ΨMP glycosidase. The green arrows represent β-strands and 
blue cylinders α-helices.  The first and last residue number of each secondary 
structural element is indicated. 
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bridges to the ΨMP phosphate.  The water molecules directly involved in Mn(II) 
interactions are involved in additional hydrogen bonding interactions that extend into 
the remainder of the active site. 
Figure 2.3.  Stereoview of Mn(II) binding site.  Water molecules and protein atoms in 
the first and second coordination sphere are shown.  The sulfate ion results from the 
crystallization conditions and occupies the phosphate binding site. 
ΨMP Glycosidase Active Site.  The active site, as defined by the structure of 
the K166A/ΨMP complex, is located in a cleft formed by helices α12, α13 and the 
loops following strands β2, β7, and β8 (Figure 2.4 A, B).  The ΨMP ribose is in a C3´-
endo conformation, the glycosidic torsion angle is anti, and the C4´-C5´ bond is in 
gauche, trans conformation.  Including the Mn(II) coordination sphere, the active site 
contains 19 well-ordered water molecules that are present in all three protomers.  
ΨMP is surrounded by 15 of the water molecules and these mediate many of the active 
site contacts with the protein.  One of the ΨMP phosphate oxygen atoms forms 
hydrogen bonds with W1 from the Mn(II) coordination sphere, Lys93, and water 
molecule W11.  A second phosphate oxygen atom forms hydrogen bonds with W2 
from the Mn(II) coordination sphere, Ser147 and water molecule W10.  The third 
phosphate oxygen atom forms hydrogen bonds with three water molecules (W7-W9), 
which interact through multiple contacts with the protein (Ser95, Thr112, Ala148NH,  
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Figure 2.4.  ΨMP glycosidase active site.  (A) Stereoview of the K166A/ΨMP active 
site.  ΨMP was observed in the active site when cocrystallizing K166A with either 
ΨMP or R5P and uracil.  ΨMP and Mn(II) form extensive hydrogen bond connections 
with the active site residues and water molecules.  The dashed lines represent 
interactions provided by the residues that make up the hydrogen bond network.  (B) 
Schematic diagram of K166A/ΨMP.  
Asp149, and Glu179*).  The ribose O2´-hydroxyl group hydrogen bonds to Glu31, the 
O3´-hydroxyl group hydrogen bonds to Asp149 and the Val113 amide group, while 
O4´ hydrogen bonds with water molecule W12, which in turn hydrogen bonds to 
Lys93 and W19. 
The ΨMP uracil forms no direct hydrogen bonds with protein residues; 
however, N1, O2, N3, and O4 form hydrogen bonds with five water molecules.  One 
water molecule (W14) hydrogen bonds to N1 and W15 and bridges to the ΨMP 
phosphate through two additional water molecules (W10 and W13).  The second water 
molecule (W16) hydrogen bonds to O2, the side chain of Asn289, W17, and W18, 
which is positioned over the center of the uracil ring and hydrogen bonds to the amide 
nitrogen and carbonyl oxygen atoms of Gly132.  The third water molecule (W15) also 
hydrogen bonds to O2, the amide nitrogen atom of Ala166 and W14.  The fourth water 
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molecule (W18) hydrogen bonds to N3, the carbonyl oxygen atom of Gly38, and the 
side chain of Asn289.  The fifth water molecule (W19) hydrogen bonds to O4, the 
carbonyl oxygen atom of His37 and an additional water molecule (W12), which 
hydrogen bonds to O4´ of ΨMP and Lys93. 
Structure of ΨMP Glycosidase/Ring-opened Ribose ΨMP Adduct. The 
structure of ΨMP glycosidase cocrystallized with R5P and uracil shows ring-opened 
ribose ΨMP covalently attached to Lys166.  Ring opening and closing is correlated 
with an approximately 90° rotation and a 2 Å shift of the uracil (Figure 2.5 A, B), thus 
occupying a different binding site compared to the K166A/ΨMP complex.  In this 
binding site, O2 forms a hydrogen bond with Asn289.  The ring-opened ribose retains 
hydrogen bonds between the 2´-hydroxyl group and Glu31, and between the 3´-
hydroxyl group and Asp149; however, the hydrogen bond to O3´ requires a rotation of 
the Glu31 carboxylate about the Cγ-Cδ bond compared to the ΨMP complex.  The 
phosphate group maintains the same position as in the K166A/ΨMP structure and 
forms hydrogen bonds with Lys93, Ser147, W1, W2, and W7-W11.  The water 
molecules near the uracil are not well defined, possibly owing to the lower resolution 
(2.5 Å) of this structure. 
Structure of the ΨMP Glycosidase/R5P Adduct. Crystals of ΨMP treated with 
R5P show a structure in which the R5P is in the ring-opened form and is covalently 
attached to Lys166 via an imine.  The R5P superimposes closely with the ring-opened 
ribose in the ΨMP adduct and forms hydrogen bonds between the 2-hydroxyl group 
and Glu31, and between the 3-hydroxyl group and Asp149 (Figure 2.5 B, C).  The 
phosphate binding site is essentially the same as for the previous complexes.  Water 
molecules in the uracil binding site are less ordered and more variable from protomer 
to protomer compared to the K166A/ΨMP complex.  
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Figure 2.5. Comparison of ΨMP glycosidase complexes. (A) Stereoview of the 
K166A/ΨMP complex.  (B) Stereoview of the ΨMP glycosidase/ ring-opened ribose 
ΨMP adduct.  (C) The ΨMP glycosidase/R5P adduct.  Protein carbon atoms are 
shown in green; ligand carbon atoms in yellow. 
Detection of a Lys166 R5P Covalent Adduct by Mass Spectrometry.  The mass 
of wild type ΨMP glycosidase was determined to be 35,453.7 Da by ICR-MS analysis  
 (Figure 2.6 A).  The mass of the reduced R5P complex was 35,669.7 Da 
corresponding to a mass increase of 216 Da. This is consistent with a doubly  
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Figure 2.6. Analysis of the R5P adduct by mass spectrometry. (A) ICR-MS data for 
the identification of the borohydride reduced ΨMP glycosidase/R5P adduct.  The 
observed 179 Da adduct corresponds to enzyme gluconoylation (36). (B) MS 
chromatograms of the control sample.  The black trace corresponds to the unmodified 
peptide while the red trace refers to the R5P bound peptide, which is not seen in the 
ΨMP glycosidase control.  (C) Triply charged state of the unmodified peptide in the 
control ΨMP glycosidase sample.  (D) MS chromatograms of the reduced ΨMP 
glycosidase/R5P adduct.  The pink trace corresponds to the unmodified peptide while 
the green trace corresponds to the R5P bound modified peptide.  (E) Triply charged 
state of the R5P bound modified peptide in the reduced ΨMP glycosidase/R5P adduct.  
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protonated reduced R5P-derived imine (216 Da).  Adduct formation was not observed 
when only uracil was incubated with ΨMP glycosidase.   
The site of imine formation was identified by trypsin digestion of the reduced 
ΨMP glycosidase R5P adduct (Figure 2.6 B-E).  Trypsin cleaves after lysine and 
arginine residues and lysine modification blocks the cleavage reaction. Trypsin 
digestion of the unmodified enzyme yielded the peptide 
GAEHTFDISADLQELANTNVTVVCAGAK (Mass = 2930.4079 Da, amino acids 
139-166).  For glycosidase incubated with R5P, trypsin digestion yielded the peptide 
GAEHTFDISADLQELANTNVTVVCAGAKSILDLGLTTEYLETFGVPLIGYQTK 
(Mass = 5896.8759 Da, amino acids 139-191). This demonstrates that Lys166 is the 
R5P modified residue. This was confirmed by similar MS analysis of the K166A 
mutant for which no mass increase was observed for the R5P treated sample.  
 Steady State Kinetics of EcΨMP Glycosidase and its Mutants.  Steady state 
kinetic parameters were determined by measuring the production of ΨMP during the 
reverse reaction while varying the uracil concentration (Figure 2.7).  Michaelis-
Menten analysis for the native enzyme indicated a Km value of 169.6 µM for uracil 
and a kcat 3.74  s-1, corresponding to a catalytic efficiency, kcat/Km, of 22 x 103 M-1 s-1. 
Steady state kinetic parameters were also determined for the active site mutants 
E31A, K93A, K166A and N289A (Table 2.3) (Figure 2.7). The activity of D149A was 
below the detection limit even at an enzyme concentration as high as 100 µM.  K93A 
has a higher Km value compared to wild type enzyme.  E31A, K93A, K166A and 
N289A have significantly lower kcat values, with E31A and K166A showing the 
largest effects. 
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Figure 2.7.  Steady state kinetics for ΨMP glycosidase and mutants in the ΨMP 
formation reaction. (A) ΨMP glycosidase.  (B) E31A. (C) K93A. (D) H137A. (E)  
K166A. (F) N289A.   
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Table 2.3. Steady state kinetic parameters for ΨMP glycosidase and mutantsa. 
a All the kinetic parameters were measured based on the ΨMP formation reaction. 
b No activity was observed at the level of detection of the assay. 
Circular Dichroism for D149A.  To determine whether the mutant was 
properly folded, we examined the CD spectra of the wild-type protein and the D149A 
mutant.  As Mn(II) is shown to be important for the activity of the enzyme, 300 μM 
MnCl2  was added for comparison. The spectra of the proteins alone and in the 
presence of Mn(II) are shown in Figure 2.8.  The approximate helical content for all 
the four species are all 84.27% (35, 37), indicating very little secondary structural 
change due to the mutation. 
Section 2.4. Discussion  
Comparison with Other Protein Structures.  A structural similarity search for 
ΨMP glycosidase was performed using DALI (38).  Not surprisingly, PDB ID 1VKM, 
which was used as the search model during molecular replacement, showed the 
highest similarity with a Z score of 42.2 (sequence identity 39%).  PDB ID 1VKM 
was originally reported by a structural genomics group to be an indigoidine synthase 
(IndA)-like protein from T. maritima (26).  Subsequent biochemical studies 
conclusively demonstrated that this protein is a ΨMP glycosidase (4).  The structure of 
Enzyme kcat  (s-1) Km (μM) kcat/ Km  (mM
-1
 
s-1) 
ΨMP glycosidase 3.74±0.14 171±22 21.9±3.6 
E31A 0.0025±0.0001 92.2±11.7 0.027±0.005 
K93A 0.22±0.01 295±19 0.75±0.01 
H137A 3.22±0.05 589±72 5.44±0.75 
D149A NDb ND ND 
K166A 0.0013±0.000052 154.6±19.4 0.0084±0.0001 
N289A 0.224±0.005 190.6±13.8 1.15±0.12 
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Figure 2.8. The CD spectra of ΨMP glycosidase and the D149A mutant with and 
without the addition of MnCl2.  The CD spectra of the wild type protein was colored 
blue.  The D149A mutant was colored red.  The wild type protein with Mn(II) added 
was colored green.  The D149A mutant with Mn(II) added was colored purple.  
the EcΨMP glycosidase is trimeric.  The structure of ΨMP glycosidase from T. 
maritima (TmΨMP glycosidase) is hexameric in the crystal structure; however, this 
hexamer is an artifact resulting from face-to-face packing of two trimers, in which 
pairs of N-terminal His-tags are joined by metal ions.  Each of the TmΨMP 
glycosidase trimers is homologous to the EcΨMP glycosidase trimer, and both 
enzymes contain a bound Mn(II).  The trimer formation is important for the ligand 
binding since the metal binding site is positioned right between two protomers.  
TmΨMP glycosidase was reported to copurify with an unknown bound ligand 
that resembled a ring-opened sugar phosphate (26).  Motivated by our structural 
results, we reexamined this electron density and found that in some protomers a ring-
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opened R5P covalently attached to a lysine residue (equivalent to Lys166 in EcΨMP 
glycosidase) provided a good fit to the electron density while in others the ribose was 
in the ring-opened form but did not appear to be covalently attached. 
Mechanistic Implications. The mechanism of Ψ synthase has been extensively 
studied and is outlined in Figure 2.9 (39). The microscopic reversibility of this 
reaction would seem to be a reasonable starting hypothesis for the reaction catalyzed 
by ΨMP glycosidase.  In this proposal, tautomerization of ΨMP 2 to give 9 followed 
by C-glycosyl bond cleavage and trapping of the resulting oxocarbenium ion would 
give 7 and 8.  Hydrolysis of 8 and protonation of 7 would complete the reaction. 
Figure 2.9. Mechanism of pseudouridine formation.  This mechanism suggested a 
plausible starting mechanistic hypothesis for ΨMP glycosidase. 
Our structural studies identified four snapshots of the EcΨMP glycosidase 
reaction coordinate.  Wild type EcΨMP glycosidase showed the unliganded state, 
although a sulfate ion from the crystallization solutions occupied the phosphate 
binding site.  Incubation of the K166A mutant with R5P and uracil resulted in a 
structure with the substrate ΨMP bound in the active site.  Native EcΨMP glycosidase 
incubated with R5P and uracil showed an intermediate in which ring-opened ribose 
ΨMP is covalently attached to Lys166.  Finally, EcΨMP glycosidase incubated with 
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R5P alone resulted in a structure with ring-opened R5P attached to Lys166.  The last 
structure is similar to that of the 1VKM complex reported to contain an unknown 
ligand (26).  This series of structures demonstrated that the ΨMP glycosidase 
catalyzed reaction occurs by a mechanism that is significantly different from the 
microscopic reverse of the Ψ synthase mechanism.   
An alternative mechanistic proposal is outlined in Figure 2.10.  Ring opening 
of the ΨMP ribose gives 10. This reaction requires acid base catalysis.  As no amino 
acids are apparent in the structure for this role (Figure 2.4), the ring opening reaction  
Figure 2.10.  Mechanistic proposal for ΨMP glycosidase. 
probably occurs by a water-mediated protonation/deprotonation reaction.  The 
conformation of the C-glycosidic bond is reasonable for a concerted process (the C6-
C5-C1-O4a dihedral angle is 50º, while the optimal angle would be 90º).  Related 
ribose ring opening reactions are catalyzed by GTP cyclohydrolase (40).  Following 
ribose ring opening, Lys166, undergoes a conjugate addition to the C-C double bond 
of 10 to give 11 with the proton coming from Glu31.  Subsequent cleavage of the C-C 
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glycosidic bond by a retroaldol type reaction releases the uracil anion, which is 
stabilized by hydrogen bonding of N1 to the hydroxyl of Thr130 and the amide NH of 
Gly131 and Gly132.  Surprisingly, there are no stabilizing hydrogen bonds to the C2 
or C4 carbonyl oxygen atoms of uracil.   Hydrolysis of imine 12 gives 13, which will 
then cyclize to 3.  In addition to the structures, the covalent linkage between Lys166 
and the substrate is supported by the characterization of the R5P Lys166 imine by 
mass spectrometry.  An alternative mechanism in which Lys166 displaces the 
pyrimidine from the ribose, as found for example in 8-oxoguanine DNA glycosylase 
(41), is unlikely.  Lysine 166, modeled into the structure of the enzyme ΨMP complex, 
is not suitably positioned for direct base displacement and the structure of the ring-
opened ribose ΨMP complex is not consistent with this mechanism. The structure of 
UrdGT2, with the substrates modeled into the active site, suggests that this C-C 
glycosyl transferase does not use an imine intermediate (24).  Our analysis suggests 
that ΨMP glycosidase may use a new glycosidase mechanism.  
This mechanistic proposal enables us to suggest testable functions for the 
active site residues.  Lys166 plays a key role in facilitating the C-glycosyl bond 
cleavage reaction and as expected the kcat value of the K166A is 2900-fold lower than 
wild type, with no change in Km.  It is interesting that low levels of catalytic activity 
are observed for this mutant, suggesting that water can replace lysine in the mutant.  
Glu31 is likely to be the proton source for the lysine conjugate addition reaction (10 to 
11 in Figure 2.10).  Consistent with this role, the kcat value of the E31A mutant is 
7500-fold lower than wild type, with little change in Km.  Lys93 contributes one of 
several interactions involved in phosphate binding.  The kcat value of the K93A mutant 
is 17-fold lower than wild type, with only a modest increase in Km.  Asn289 hydrogen 
bonds to two water molecules that are in turn hydrogen bonded to the C2 carbonyl and 
to N3. These interactions stabilize negative charge on the uracil in the conversion of 
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11 to 12 and 4.  Consequentially, the kcat value of the N289A mutant is 17-fold lower 
than wild type, with a small increase in Km.  Asp149 forms a hydrogen bond to the 
substrate C3´ alcohol.  We would therefore expect that the activity of D149A mutant 
would be comparable to wild type, which is inconsistent with our finding that it shows 
no detectable activity.  One possibility is that the D149A mutant has misfolded; 
however, circular dichroism spectra of wild type and D149A are nearly identical 
(Figure 2.8).  Another possibility is that Asp149 serves indirectly as an acid/base 
through a charged network. 
The Role of the Hydrated Metal Binding Site.  Both EcΨMP glycosidase and 
TmΨMP glycosidase contain a heavily hydrated, octahedrally coordinated Mn(II) ions 
in which the ligands are an aspartate side chain and five water molecules.  This 
heavily hydrated metal binding site is unusual and likely plays a role in anchoring the 
ΨMP phosphate.  In addition, the water molecules in the second sphere (W6-W9) are 
also present in both structures, and all side chains in the second sphere are conserved, 
including a Glu176 and Glu179 from the neighboring protomer. Two phosphate 
oxygen atoms form hydrogen bonds to W1 and W2, which are in the Mn(II) 
coordination sphere.  The phosphate group also hydrogen bonds to Ser147 and Lys93, 
which are conserved in both structures.  While the ribose and uracil both undergo 
movement during catalysis, the phosphate remains in the same position, with no 
hydrogen bonding changes.  ΨMP glycosidase shows highest activities with Fe(II), 
Co(II) and Mn(II), while Zn(II), and to a lesser extent, Ni(II), were inhibitory (4).  
These observations suggest that the ionic radius of the metal ion may play a role in 
properly positioning the substrate. 
Role of Conformational Changes in Catalysis.  Both the protein and substrate 
undergo conformation changes during catalysis.  The uracil undergoes a 90° rotation 
and a 2 Å shift after ring opening and Lys166 adduct formation.  In the glycosidase 
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ΨMP complex, uracil forms no hydrogen bonds with protein atoms; however, after 
shifting position, uracil hydrogen bonds through O2 to Asn289, which is located at the 
opposite end of the active site relative to the phosphate.  Repositioning of the uracil 
also places N1 near the amide nitrogen atoms of Gly131 and Gly132, which are 
absolutely conserved.  Heavy reliance in the binding site on water-mediated 
interactions is consistent with the need for major repositioning of an intermediate 
during catalysis. 
Comparison of the 12 protomers (three each from four structures) suggests that 
conformational changes in the protein are also involved in catalysis.  The largest 
differences occur in helices α11 and α12 with RMSDs ranging from 1.5 - 7.0 Å for 
the pairwise comparisons.  At one extreme these residues insert into the active site, 
acting as a gate.  At the other extreme these residues are extended away from the 
active site making room for substrate binding.  In all of the structures, these residues 
tend to show weaker electron density and higher B-factors.  A second region of 
structural variation occurs in residues 130-150 (α7 and α8) and 162-200 (helix α9 and 
β9) with RMSDs ranging from 1.5 to 5.0 Å.  This region contains 14 of 17 absolutely 
conserved residues.  While crystal packing may also play a role in the variation among 
protomers, the differences are consistent with gating of the active site and positioning 
of catalytically important residues. 
Conclusion.  The ΨMP glycosidase complexes described in this paper give 
four snapshots of the reaction coordinate and provide key structural insights into the 
enzymatic hydrolysis of C-glycosides.  Most glycosidases utilize a dissociative 
mechanism to reversibly cleave C-N and C-O glycosidic bonds.  In contrast, the 
structural and biochemical studies reported here demonstrate that ΨMP glycosidase 
utilizes a mechanism involving ribose ring opening and subsequent covalent linkage 
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between C1´ and an active site lysine, thus setting the stage for a facile C-glycosyl 
bond fragmentation by a novel retroaldol type mechanism.  
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CHAPTER 3 
THIAMIN PYRIMIDINE BIOSYNTHESIS IN CANDIDA ALBICANS: 
A REMARKABLE REACTION BETWEEN HISTIDINE 
AND PYRIDOXAL PHOSPHATE1 
Section 3.1. Introduction 
The thiazole 7 and the pyrimidine 10 heterocycles of thiamin are 
biosynthesized in Saccharomyces cerevisiae using chemistry that is fundamentally 
different from the bacterial pathway (1, 2) (Figure 3.1). In bacteria the thiazole is 
formed from deoxy-D-xylulose 5-phosphate, glycine (or tyrosine) and cysteine and the 
pyrimidine is formed from aminoimidazole ribotide(3).  In contrast, in S. cerevisiae 
the thiazole 7 is formed from NAD, glycine and an active site cysteine of the THI4 
protein (4) and the 4-amino-2-methyl-5-hydroxymethyl pyrimidine phosphate (HMP-
P) (10) is formed from histidine and pyridoxal phosphate (PLP) (5-9). The origin of all 
of the atoms of HMP-P has been determined as shown in Figure 3.1 and suggests that 
HMP-P (10) is formed using remarkable chemistry that is without chemical or 
biochemical precedent.  Genetic studies have demonstrated that HMP-P formation 
requires only a single gene (THI5) (10). Here we report the overexpression of THI5p, 
the reconstitution of the enzymatic activity, the preliminary characterization of the 
reaction and a structure of the enzyme/PLP complex.  These experiments suggest that 
the THI5 protein is the histidine source for HMP-P formation and that THI5p is a 
single turnover enzyme.  
 
 
                                                 
1 Produced with permission from Lai R., Huang S., Fenwick M. K., Hazra A., Zhang 
Y., Rajashanka K., Philmus B., Kinsland C., Sanders J. M., Ealick S. E., Begley T. P., 
(2012), J. Am. Chem. Soc., 134 (22), 9157-9159.  Copyright © American Chemical 
Society 
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Figure 3.1. Thiamin pyrophosphate biosynthesis in S. cerevisiae 
Section 3.2. Materials and Methods 
THI5p Overexpression and Purification.  E. coli BL21(DE3) containing the 
THI5 gene in pET28b was grown in minimal medium (11.3 g M9 salts, 13.3 mL 50% 
glucose, 2.7 mL 1M MgSO4, 100 L 1M CaCl2 diluted to 1 L medium) containing  
Kanamycin (40 g/mL) with shaking at 37 °C until the OD600 reached 0.6.  At this 
point, protein overexpression was induced with IPTG (final concentration, 500 M), 
and cell growth was continued at 15 °C for 16 h.  The cells were harvested by  
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centrifugation, and the cell culture were resuspended in 20 mL of lysis buffer (10 mM  
imidazole, 300 mM NaCl,pellets from 1 L of 50 mM NaH2PO4, 5 mM DTT, pH 8) 
and lysed by sonication (Heat System Ultrasonics model W-385 sonicator, 1.5 s cycle, 
60% duty).  The resulting cell lysate was clarified by centrifugation and THI5p was 
purified on a Ni-NTA column following the manufacturer’s instructions. After elution, 
the protein was desalted under anaerobic conditions using a 10-DG column (BioRad) 
pre-equilibrated with 100 mM Tris-HCl buffer, 5 mM DTT, 30% glycerol, pH 7.5.  
The purified protein was stored in aliquots in liquid nitrogen. 
Reconstitution of the THI5p Activity.  100 L of 600 uM THI5p was 
anaerobically pre-incubated with 1.5 equivalents of Fe(NH4)2(SO4)2 in an ice bath for 
30 min.  The mixture was anaerobically desalted using a Bio-Spin 6 column (Bio-Rad) 
pre-equilibrated with 100 mM Tris-HCl, 5 mM DTT, pH 7.5. Subsequently, 2 
equivalents of PLP were added.  The reaction mixture was aerobically incubated at 
room temperature for 3 h, filtered using a 10 kDa MW cutoff filter, and analyzed by 
HPLC and LC-MS. Aerobic preincubation gave lower yields of product (>2 fold 
reduction).  The reconstitution was run using 0.5, 1, 2, 3 and 4 equivalents of PLP.  
Two equivalents of PLP gave the highest level of product production. 
HPLC Conditions for Analyzing the THI5p Reaction mixture.  The following 
linear gradient, at a flow rate of 2 mL/min, on a Supelcosil LC-18 column (250 mm x 
10 mm, 5 m ID) was used: solvent A is water, solvent B is 100 mM potassium 
phosphate, pH 6.6, solvent C is methanol; 0 min: 100% B; 5 min: 10% A, 90% B; 10 
min: 25% A, 60% B, 15% C; 13 min: 25% A, 60% B, 15% C; 17 min: 30% A, 10% B, 
60% C; 18 min: 30% A, 10% B, 60% C; 21 min: 100% B; 30min: 100% B. 
15N-THI5p Overexpression and Purification.  The overexpression and 
purification procedures were the same as described above for THI5p except 14NH4Cl 
was replaced by 15NH4Cl in the M9 salts.  
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LC-MS Analysis of the THI5p reaction mixture. The following linear gradient, 
at a flow rate of 0.4 mL/min, on a Supelcosil LC-18-T column (150 mm X 3 mm, 3 
m ID) was used: solvent A is 20 mM NH4OAc, pH 6.6, solvent B is 75% methanol; 0 
min: 100% A; 3 min: 100% A; 8 min: 50% A, 50% B; 10 min: 100% A; 20 min: 
100% A.  The HPLC is coupled with a microTOF-Q II for MS analysis in the positive 
mode. 
Trypsin Digestion of inactive THI5p.  After completion of PLP formation, the 
inactive THI5p (50 g, 1.8 l of 660 M THI5p) was added to 10 L of 6 M 
guanidine-HCl, 25 mM ammonium bicarbonate, pH 8. 1 L of 200 mM DTT in 25 
mM ammonium bicarbonate pH 8, was then added to the denatured protein solution 
and the resulting mixture was incubated at room temperature for 1 h.  After that, 10 L 
of 200 mM iodoacetamide in 25 mM ammonium bicarbonate pH 8, was added and the 
reaction mixture was incubated at room temperature in the dark for 1 h.  Finally, 77.5 
L of 25 mM ammonium bicarbonate pH 8, was added to reduce the guanidine-HCl 
concentration to 0.6 M followed by the addition of 1 g of trypsin.  The mixture was 
incubated at 37 °C overnight and stored at -20 °C until analysis. 
LC-MS Conditions for Analyzing THI5p Samples after Trypsin Digestion.  The 
following linear gradient, at a flow rate of 0.4 mL/min, on a Synergi Polar-RP 100A 
column (50 mm X 2 mm, 2.5 microns) was used: solvent A is 0.1% formic acid in 
water, solvent B is 0.1% formic acid in acetonitrile; 0 min: 95% A, 5% B; 1 min: 
100% A; 60 min: 35% A, 65% B; 61 min: 100% B; 62 min: 100% B; 64 min: 95% A, 
5% B; 65.5 min: 95% A, 5% B.  The HPLC is coupled with a microTOF-Q II for MS 
analysis in the positive mode. 
THI5p Refolding Experiments.  1 mL of 700 M THI5p was added to 25 mL of 
denaturing buffer (50 mM KH2PO4, 300 mM NaCl, 5 mM mercaptoethanol, 8 M urea, 
pH 7.8) and incubated at room temperature for 1 h.  The solution was then transferred 
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to a Slide-A-Lyzer Dialysis Cassette, 10K MWCO (Thermo Scientific) and dialyzed 
against 2 L of dialysis buffer (50 mM KH2PO4, 300 mM NaCl, 5 mM 
mercaptoethanol, 5 M urea, pH 7.8) for 5 h.  Subsequently, the cassette was 
transferred to the next buffer (50 mM KH2PO4, 300 mM NaCl, 5 mM 
mercaptoethanol, 2M urea, pH 7.8) and dialyzed overnight.  The protein solution was 
then loaded onto a 5 mL Ni-NTA column pre-equilibrated with 50 mM KH2PO4, 300 
mM NaCl, 5 mM mercaptoethanol, 2 M urea, pH 7.8.  The Ni-NTA column was 
installed on an FPLC and eluted, at a flow rate of 1 mL/min, with the following linear 
gradient: solvent A is 50 mM KH2PO4, 300 mM NaCl, 5 mM mercaptoethanol, 2 M 
urea, pH 7.8; solvent B is 50 mM KH2PO4, 300 mM NaCl, 5 mM mercaptoethanol, 
pH 7.8; 0 min: 100% A; 120 min: 100% B.  Finally, the refolded protein was eluted 
with 200 mM imidazole, 50 mM KH2PO4, 300 mM NaCl, 5 mM mercaptoethanol, pH 
7.8. After concentration, the protein solution was buffer-exchanged using a Bio-Spin 6 
Column (Bio-Rad) into 100 mM Tris-HCl, 5 mM DTT, pH 7.5.  The activity of the 
refolded THI5p protein was determined as described above for the native enzyme.  
Mutagenesis of THI5p. The mutants shown in Table S1 were constructed.  The 
activity of each mutant was determined as described above for the native enzyme.  
Most of the H18A mutant overexpressed as inclusion bodies, however a very small 
amount of this mutant could be purified from the crude lysate and was found to be 
active.  
Crystallization of CaTHI5p.  Initial attempts to crystallized S. cerevisiae 
THI5p were unsuccessful.  We then cloned and overexpressed a collection of THI5p 
orthologs.  Of these, CaTHI5p produced high quality crystals, which were used for all 
crystallographic studies. For crystallization experiments, the poly-histidine tag of 
CaTHI5p was removed by thrombin cleavage.  A total of 0.45 mg thrombin from 
bovine plasma (Sigma Aldrich) was added to 8 mL of reaction mixture containing 2.5 
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mg/mL CaTHI5, 10 mM Tris, pH 7.5, 20 mM NaCl and 1 mM DTT.  This solution 
was incubated overnight at 4 °C with shaking.  The sample was subjected to a second 
round of nickel-chelate chromatography to remove uncleaved protein, followed by 
size exclusion chromatography using a HiLoad 26/60 Superdex 200 prep grade 
column (GE Healthcare).  The protein purity as judged by SDS-PAGE analysis was 
higher than 95 %.  The protein was buffer-exchanged into 20 mM NaCl, 10 mM Tris, 
pH 7.5, and concentrated to 15 mg/mL for crystallization experiments. 
CaTHI5p was cocrystallized with 1 mM PLP using the hanging-drop vapor 
diffusion method at 22 °C.  The initial drops consisted of a 1 L of protein solution 
and 1 L of reservoir solution.  The optimized reservoir solution was 20 % (w/v) PEG 
3350 and 0.2 M ammonium chloride.  Rod-shaped crystals grew within one day to the 
size of 500 μm × 10 μm × 10 μm.  The crystals were briefly soaked in 20 % (w/v) 
PEG 3350, 0.2 M ammonium chloride and 15 % glycerol prior to vitrification in liquid 
nitrogen. 
Crystallization of CaTHI5p-H66G. The poly-histidine tag of CaTHI5p-H66G 
was cleaved following a similar procedure as described above for the wild type 
protein, except 1 mg thrombin was added to 14 mL of reaction mixture containing 4.5 
mg/mL CaTHI5p-H66G, 25 mM Tris and 150 mM NaCl, pH 7.8.  The final sample 
was in a buffer of 30 mM NaCl and 10 mM citrate, pH 6.5, at a protein concentration 
of ~10 mg/mL for crystallization experiments. 
CaTHI5p-H66G was crystallized using the hanging drop vapor diffusion 
method at 22 C.  The drops consisted of 1.5 L of protein solution and 1.5 L of 
reservoir solution.  The optimized reservoir solution contained 15 % (w/v) 
polyethylene glycol (11) 4000 and 100 mM citrate, pH 5.3.  The crystals were briefly 
soaked in a cryosolution containing 25 mM citric acid (pH 5.2), 38 % (w/v) PEG 
4000, and 5 mM DTT prior to vitrification in liquid nitrogen.  
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Structure Determination of CaTHI5p-H66G.  The structure of CaTHI5p-H66G 
was determined by single wavelength anomalous diffraction phasing using CaTHI5p-
H66G crystals soaked in the cryosolution supplemented with 1.0 M NaBr for 
approximately 1 min (12).  X-ray data were measured at 100 K at NE-CAT beamline 
24-ID-C of the Advanced Photon Source.  420 images were recorded from one crystal 
using a PILATUS-6MF (Dectris) detector.  Diffraction data were integrated and scaled 
to 2.0 Å resolution using HKL2000 (13).  The space group of the crystal was P212121 
with unit cell parameters a = 55.0 Å, b = 99.8 Å, and c = 126.5 Å.  Heavy atom sites 
were identified using SHELXD (14, 15) via HKL2MAP (16).  SAD phasing, density 
modification, and initial model building were performed using MLPHARE (17), 
Parrot (18), and RESOLVE (19), respectively.  The model was completed using 
COOT (20) to perform manual building alternated with refinement using REFMAC5 
(21) and PHENIX (9) The final structure of CaTHI5p-H66G, with one homodimer per 
asymmetric unit, was subsequently refined against a higher resolution data set at 1.6 Å 
resolution.  Complete main chains were built for each protomer and only eight side 
chains were missing atoms and incomplete.  A difference Fourier map showed that 
each protomer contained a citrate molecule in the proposed active site.  The final 
structure had an R factor of 17.3 % and Rfree of 20.2 %.   X-ray diffraction and 
refinement statistics are provided in Tables 1 and 2, respectively. 
Structure Determination of CaTHI5p/PLP.  X-ray diffraction data for 
CaTHI5p/PLP were collected at 100 K using the Advanced Photon Source NE-CAT 
beamline 24-ID-C and a PILATUS-6MF detector (Dectris).  Crystals of the 
CaTHI5/PLP complex diffracted to 2.2 Å resolution.  The space group was P212121 
and the unit cell parameters (a = 55.16 Å, b = 100.46 Å, and c = 126.20 Å) were 
similar to those of CaTHI5p-H66G.  The data were indexed, integrated and scaled 
using HKL2000 (13).  The structure was determined using the structure of CaTHI5-  
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Table 3.1.  Data Collection Statistics. 
 Br-CaTHI5p-
H66G 
CaTHI5p-
H66G 
CaTHI5p/PLP 
beamline APS 24-ID-C APS 24-ID-C APS 24-ID-C 
wavelength (Å) 0.9194 0.9792 0.9795 
Space group P212121 P212121 P212121 
a (Å) 55.0 55.4 55.0 
b (Å)  99.8 99.5 99.7 
c (Å)  126.5 126.4 123.4 
Resolution range (Å) 50.0–2.0  
(2.07–2.00)a 
50.0–1.6  
(1.63–1.60) 
48.4–2.2  
(2.34–2.20) 
No. of reflections 718,132 395,599 182,558 
No. of unique reflections 90,983; 43,071b 92,106 36,139 
Redundancy 7.9 (7.8) 4.3 (4.3) 5.1 (5.0) 
Completeness (%) 99.9 (99.9) 99.1 (99.2) 98.9 (99.8) 
<I>/<I>c 18.8 (4.2) 22.7 (3.3) 14.5 (2.3) 
Rmerge (%)d 10.4 (56.3) 6.0 (48.1) 10.5 (69.0) 
 
aValues in parentheses correspond to the highest resolution shell.  bNumber of Bijvoet 
pairs.  c< > indicates mean; I denotes intensity, and I represents the standard 
deviation of I.  d , where NU is the total 
number of unique reflections and Ni is the number of reflections measured for a given 
i = hkl. 
  
       U iU i Ni Nj jNi Nj ijmerge IIIR 1 11 1 /
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Table 3.2.  Data Refinement Statistics. 
 CaTHI5p-H66G CaTHI5p/PLP 
No. of reflections 92,025 36,004 
No. of reflections in working set 87,408 34,157 
Resolution (Å) 1.60 2.20 
No. of protein atoms  5,662 4929 
No. of waters 818 318 
No. of ligand atoms 26 (citrate) 46 (PLP) 
RMSD from ideal bonds (Å) 0.006 0.007 
RMSD from ideal angles (22) 1.055 1.061 
Rwork (%)a 16.2 17.4 
Rfree (%)a 19.1 22.8 
Ramachandran analysisb   
     Most favored (%) 98.2 92.7 
     Additional allowed (%) 1.8 7.3 
     Generously allowed (%) 0.0 0.0 
     Disallowed (%) 0.0 0.0 
 
a , where |FO,i| and |FC,i| are the observed and 
calculated structure factor amplitudes for reflection i = hkl and NU is the number of 
unique reflections.  For Rfree, these sums were taken over a 5% subset of the reflections 
excluded during structure refinement.  bCarried out using PROCHECK (excludes 
glycine, proline, and end residues) (23).  
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Figure 3.6.  Sequence alignment for THI5p.  Ten diverse sequences were selected.  
Conserved residues are highlighted in red.  Residues that line the active site cavity are 
indicated by asterisks. 
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THI5p sequence has six histidine residues. Of these, His18 and His66 are absolutely 
conserved in all species.  If one of these histidine residues is the N=C-N donor, we 
would expect THI5p, after HMP-P formation (inactive THI5p) to show a mass deficit.  
However MS analysis of a tryptic digest of inactive THI5p gave fragments containing 
only five of the six-histidine residues; we were unable to identify a peptide containing 
His66 or modified His66 in samples of active and inactive enzyme.  We do not yet 
understand why the MS analysis failed to identify this peptide (Figure 3.7).  Each of 
the six histidine residues was then mutated in an alternative attempt to identify the 
histidine donor for HMP-P formation.  The H128N, H234N, H273N and H323N 
mutants were active while the H18N mutant was inclusion body, and H66N mutant 
was inactive (Table 3.3).  This suggests that one of the two absolutely conserved 
histidine residues might be the source of the N=C-N fragment. 
Table 3.3. THI5p histidine mutants and their activities 
 
 
H18N
H66N
H128N
H234N
H273N
H323N
H18D
H18A
H66G
Inclusion body
Active
Active
Active
Active
Inactive
Inclusion body
Inclusion body
Inactive
Mutant Mutant
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Figure 3.9. Mechanistic proposal for the formation of HMP-P from PLP and the active 
site His66.  
Tautomerization to 16 followed by imine hydrolysis gives 17.   Fe(III) mediated 
oxidation of the tertiary amine of 17 gives 18, which can then undergo two radical 
mediated β-scission reactions to give 20.  After oxygen mediated regeneration of 
Fe(III), oxidation of 20 gives 22.   A substitution reaction, possibly mediated by 
Cys199 releases the HMP-P 10 from the protein.  Hydrolysis of heterocumulene 21 to 
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24 completes the reaction.   Many features of this proposal are readily testable.  For 
example, Extended X-ray Absorption Fine Structure and Electron Paramagnetic 
Resonance Spectroscopy can be used to identify the iron binding site coordination and 
the oxidation state of iron.  Different mutants and reactions can be introduced to 
explore different intermediate conditions throughout the reaction and elucidated using 
Mass Spectrometry and X-ray Crystallography.  Homologs of THI5p from other 
species can also be introduced to systematically study this suicidal behavior of the 
protein. 
 In conclusion, active THI5p can be readily overexpressed in E. coli.  The 
protein uses PLP and the active site His66 to form HMP-P.  This reaction requires 
oxygen and Fe(III) and generates inactive THI5p.  A structure of C. albicans THI5p 
shows PLP bound at the active site via an imine with Lys62 and His66 in close 
proximity to the PLP.  A mechanistic proposal for a reaction between His66 and PLP 
to generate HMP-P is described and demonstrated the unprecedented chemistry for 
this suicidal enzyme.  In this reaction, THI5p not only serves as an enzyme, but also a 
co-substrate for the formation of HMP-P and becomes inactive after a single turnover.  
This suicidal behavior of enzymes is exceedingly rare in nature (24, 25) and the 
biological function of this modified enzyme, if any, has not yet been revealed.  
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CHAPTER 4 
OXIDATIVE MODIFICATION OF CYSETINE INTO SULFONIC ACID IN 
SUICIDE ENZYME THIAMIN PYRIMIDINE SYNTHASE 
Section 4.1. Introduction 
Thiamin pyrophosphate is an essential cofactor in all living systems.  While 
bacteria, archea, and lower eukaryotes produce their own thiamin, higher eukaryotes 
cannot and require thiamin as a dietary supplement.  Deficiency of thiamin in human 
can cause beriberi (1) and WenickeKorsakoff syndrome (2).  In both prokaryotes and 
eukaryotes the thiazole and pyrimidine moieties are biosynthesized separately, and 
then coupled by thiamin phosphate synthase.  While prokaryotic biosynthesis of the 
thiazole moiety requires five gene products, eukaryotes require only one enzyme, 
THI4p, which we have shown to be a suicide enzyme (3).  THI4p cysteine residue 
serves as the thiazole sulfur source, and after one turnover the enzyme is inactive.  In 
prokaryotes and plants, biosynthesis of the pyrimidine moiety utilizes ThiC, a radical 
S-adenosylmethioninine enzyme that catalyzes the complex rearrangement of 5-
aminoimidazole ribonucleotide to form 4-amino-5-hydroxymethyl-2-
methylpyrimidine phosphate (HMP-P) (4).  In eukaryotes, HMP-P is biosynthesized 
from histidine and pyridoxal 5´-phosphate (PLP) and utilizes the enzyme THI5p.  Our 
previous biochemical and structural studies in THI5p from Candida albicans have 
demonstrated that THI5p is also a suicide enzyme (5).  A histidine residue of THI5p is 
the source of one carbon and two nitrogen atoms to complete the biosynthesis of 
HMP-P, and after one turnover THI5p is inactive.  A mechanism involving Diels-
Alder reaction between the histidine and pyridoxal phosphate (PLP) has been 
proposed (5).  Very recently another group crystallized THI5p in Saccharomyces 
cerevisiae, also showing the same PLP binding site as that in C. albicans.   
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Sequence analysis show that the THI5p family has a highly conserved CCCXC 
motif at the C-terminus.  The structures of this motif have also been shown in several 
crystal structures (5, 6).  In the structure of THI5p in S. cerevisiae, residues 187-195 
are prone to disorder as indicated by missing electron density.  Coupled with 
complementary assay for individual cysteine residue, it has been proposed that the 
cysteine-rich motif coordinates an iron atom for the HMP-P synthesis reaction (6).  
The diverse family of cysteine-rich motifs are often related to the iron and cobalt 
coordination and frequently serves as the Lewis acid in the electron transfer and 
radical reactions.  For example, the CX3CX2C motif in radical-SAM enzymes in E. 
coli serves as the binding site for [4Fe-4S] cluster (7).  A model of THI5p based on 
THIYp, a sequence homolog with 25% sequence identity, has also been proposed with 
a putative [Fe-S] cluster binding site (8).  However, no experimental evidence of [Fe-
S] cluster has been found in the structure of THI5p.  Instead, evidence shows that the 
activity of THI5p depends on Fe(III) ion (5), which leads to the hypothesis that the 
enzyme catalyzes an Fe(III)-mediated redox reaction. The binding of free iron by 
cysteine has been discovered in other proteins such as nitrile hydratases (9).  Iron-
containing nitrile hydratase share a conserved CX2CXC motif.  This motif serves as 
part of the octahedral binding site of iron, which consists of the side chains of three 
cysteines and main chain amides of another two residues (10).  These ligands provide 
five vertices of an octahedron for iron, with the sixth position unoccupied and open to 
the active site cleft.   
So far, several structures of THI5p complexed with the substrate PLP have 
been determined in fungus (5) and yeast (6).  Here we present the comparisons for 
three new structures of THI5p to the published structure THI5p/PLP complex in C. 
albicans.  The three new structures of THI5p include the modified-THI5p, the C199A 
mutant complexed with PLP and the C-terminus truncated THI5p, E309Ter, 
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complexed with PLP.  We also provide a comprehensive and detailed structural 
analysis for the previously reported THI5p/PLP complex.  Along with the support 
from the LC-MS data, the comparisons for the four structures provide further insights 
into the mechanism of this single-turnover enzyme that is without chemical or 
biochemical precedent. 
Section 4.2. Materials and Methods 
Cloning and Mutagenesis.  The THI5 gene from C. albicans (CaTHI5) 
genomic DNA was PCR amplified and the purified PCR product was digested and 
ligated into a pET28 vector as described previously (5).  The vector was then sub-
cloned into pTHT, a pET-28 derived vector for mutagenesis.  The site-directed 
mutagenesis was performed for generating a C199A mutant and a C-terminus 
truncated mutant E309Ter using a standard PCR-based protocol (11) and 
corresponding forward and reverse primers. 
Expression, Purification and Crystallization of Modified-THI5p, C199A/PLP 
complex and E309Ter/PLP complex.  The basic expression and purification 
procedures were the same as described previously (5).  After the basic steps of 
purification, the wild type THI5p and the C199A and E309Ter mutants were treated 
with iron and PLP following the same procedure as for reconstitution of THI5p 
activity.  1.5 equivalent of Fe(NH4)2(SO4)2 were added in an ice bath for 30 min.  
Then the mixture was desalted using an Econo-Pac 10DG desalting column (Bio-
RAD) pre-equilibrated with 20 mM NaCl, 10 mM Tris, pH 7.5, 3 mM DTT.  
Subsequently, 2 equivalent of PLP was added at 22 °C.  The reaction mixture was then 
incubated at room temperature for 3 h and concentrated to 15 mg/mL using an Amicon 
concentrator (30 kDa MWCO filter, Millipore), flash frozen and stored at -80 ºC. 
The initial crystallization condition was determined using sparse matrix screen 
Crystal Screen 1 and 2 (Hampton Research), Wizard III and IV (Emerald Bio).  The 
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optimized reservoir conditions were 2.5 M NaCl, 0.1 M Na/K phosphate at pH 6.2 for 
modified-THI5p, 20% (w/v) PEG3350 and 0.2 M NH4Cl for C199A/PLP complex, 
18% PEG 3350 and 0.2 M NH4Cl for E309Ter/PLP complex.  The drops contained 1 
µL of protein solution and 1 µL of reservoir solution.  Rod-shaped crystals for 
C199A/PLP and E309Ter/PLP grew within 2 days to the size of 800 µm × 20 µm × 20 
µm.   Tetragonal bipyramidal shape of modified-THI5p grew after five months to the 
size of 80 µm × 50 µm × 50 µm.  The crystals of the modified-THI5p were briefly 
soaked in 5% ethylene glycol prior to vitrification in liquid nitrogen, and in 15% 
glycerol for C199A/PLP and E309Ter/PLP complex. 
Data Collection and Structure Determination.  X-ray diffraction data of 
modified-THI5p and mutants of THI5p were collected at the NE-CAT beamline 24-
ID-E at APS using an CCD-based ADSC Quantum 315 detector (Area Detector 
Systems Corporation) at a wavelength of 0.9792 Å with 1 s exposure times and 1° 
oscillation angles.  The detector distances were 360 mm, 250 mm, 330 mm for the 
modified-THI5p, C199A/PLP, E309Ter/PLP complex, respectively.  Data were 
indexed, integrated and scaled using the HKL2000 program suite (12).  
The structure of C199A/PLP complex and E309A/PLP complex were 
determined using the previously solved structure of THI5p/PLP complex as the initial 
model and refining with PHENIX (13).  The structures of the modified-THI5p and 
E309A/PLP complex, which crystallized in different space groups, were determined 
by molecular replacement using MOLREP (13) with a monomer from the refined 
THI5p structure as the search model.  Data collection and refinement statistics are 
summarized in Table 4.1 and Table 4.2. 
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Table 4.1. Data Collection Statistics 
 
 THI5p/PLP Modified-THI5p C199A/PLP E309Ter/PLP 
beamline APS 24-ID-C APS 24-ID-E APS 24-ID-E APS 24-ID-E 
wavelength (Å) 0.9795 0.9792 0.9792 0.9792 
space group P212121 P43212 P212121 P22121 
a (Å) 55.0 89.6 54.9 55.4 
b (Å) 99.7 89.6 100.6 115.0 
c (Å) 123.4 96.2 126.5 120.4 
protomers per 
asymmetric unit 
2 1 2 2 
resolution range (Å) 50.0-2.20 50.0-1.97 50.0-1.70 50-2.34 
 (2.34-2.20) a (2.04-1.97) (1.76-1.70) (2.42-2.34) 
total no. of reflections 182,558 247,765 272,455 149,464 
no. of unique 
reflections 
36,139 28,391 77,607 33,197 
redundancy 5.1 (5.0) a 8.8 (5.4) 3.7 (3.4) 4.7 (4.2) 
completeness (%) 98.9 (99.8) a 99.1 (93.4) 94.6 (75.5) 96.8 (94.5) 
Rmerge (%) b 10.5 (69.0) a 7.9 (48.5) 4.2 (38.1) 8.9 (41.9) 
I/σ(I) 14.5 (2.3) a 28.2 (2.3) 15.6 (2.1) 10.9 (2.1) 
 
aValues in parentheses are for the highest resolution shell. 
bRmerge = ΣΣi | Ii − <Ι> | / Σ <Ι>, where <Ι> is the mean intensity of the N reflections 
with intensities Ii and common indices h, k, l. 
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Table 4.2. Data Refinement Statistics 
 
 
a , where |FO,i| and |FC,i| are the observed and 
calculated structure factor amplitudes for reflection i = hkl and NU is the number of 
unique reflections.  For Rfree, these sums were taken over a 5% subset of the reflections 
excluded during structure refinement.  b Carried out using PROCHECK (excludes 
glycine, proline, and end residues) (14).  
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 THI5p/PLP Modified-THI5p C199A/PLP E309Ter/PLP 
no. of reflections 36,004 28,082 73,352 32,086 
no. of reflections in 
working set 
34,157 26,723 69,667 30,498 
no. of protein atoms 4,929 2,303 5,232 4,806 
no. of ligand atoms 46 0 46 46 
no. of water atoms 318 134 864 420 
rmsd for bonds (Å) 0.007 0.008 0.006 0.008 
rmsd for angles (°) 1.061 1.375 1.079 1.091 
Rwork/ Rfreea (%) 17.4/22.8 18.5/20.9 15.4/18.4 16.6/21.2 
Ramanchandran 
analysisb 
    
most favored (%) 92.7 95.0 93.1 92.9 
additional allowed (%) 7.3 5.0 6.9 7.1 
generously allowed (%) 0.0 0.0 0.0 0.0 
disallowed (%) 0.0 0.0 0.0 0.0 
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LC-MS Analysis on THI5p and the Mutants.  The procedures of trypsin 
digestion and LC-MS analysis are similar as described previously (5).  In LC-MS, 
following linear gradient, at a flow rate of 0.4 mL/min, on a Synergi 2.5u polar-RP 
100A (50X2 mm) was used: solvent A is 0.1% formic acid in water, solvent B is 0.1% 
formic acid in acetonitrile; 0 min: 100% A; 1 min: 100% A; 8min: 88% A, 12% B; 
31min: 65% A, 35%B; 46min: 35% A, 65% B; 48min: 100% B; 53min: 100%B; 
56min: 100%A; 65min: 100% A.  The HPLC is coupled with a microTOF-Q II for MS 
analysis in the positive mode. 
Section 4.3. Results 
Overall Structure of THI5p.  THI5p is a homodimer with one dimer per 
asymmetric unit in the THI5p/PLP complex (Figure 4.1 A).  Of the 339 residues, the 
electron density for the 32 residues at the C-terminus of both protomers was missing 
in all the native THI5p data sets collected from C. abicans.  THI5p consists of two 
domains each containing a five-stranded mixed β-sheet (Figure 1B).  The central β-
sheet of domain I shows the topology of 2↑1↑3↑10↓4↑, flanked by three α-helices 
and two 310-helices on one side, and seven α-helices and one 310-turn on the other.  
Domain II, albeit smaller, shows a similar pattern of the β-sheet 7↑6↑8↑5↓9↑, with 
four α-helices and two 310-helices on one side and two α-helices and one 310-helix on 
the other (Figure 1C).  Domain I and II are related by pseudo-2-fold symmetry and 
joint by two crossovers: one joining β4 and β5 and the other joining η6 and α9.  Such 
central β-sheet arrangement is characteristic for the Type II periplasmic binding 
protein (PBP), featured by the central β-sheet topology of 2↑1↑3↑n↓4↑ in both 
domains, where n stands for the strand right after the first cross-over from the N-
terminus towards the C-terminus, and vice versa (15).  The overall structure of the 
protomer superimposes fairly well with the predicted homology model (8), generated 
using periplasmic N-formyl-4-amino-5-(aminomethyl)-2-methylpyrimidine (FAMP) 
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binding protein ThiY as the template, which shares 25% sequence identity and 47% 
similarity to THI5p.  In spite of variance in the number of protomers per asymmetric 
unit, THI5p from C. albicans is always shown to be a dimer built from the same 
interface.  The interface is formed by 16 hydrogen bonds and 5 salt bridges highly 
conserved in all structures, according to PISA (16-18).  Similar interface is also 
observed in the structures of THI5p from S. cerevisiae (6). 
Figure 4.1.  Overall structure of THI5p.  (A) Ribbon diagram of THI5p.  The 
protomers are colored green and grey.  The PLP in the active site is indicated by the 
space filling model in pink.  (B) Ribbon diagram of THI5p protomer is color coded by 
α-helices and 310-helices (blue) as well as β-strands (green) are labeled.  (C) Topology 
diagram of THI5p.  The blue cylinders represent α-helices and 310-helices and the 
green arrows represent β-strands.  The first and last residue number of each secondary 
structural element is indicated. 
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THI5p Active Site.  The active site, as defined by the structure of the 
THI5p/PLP complex, is positioned in the cleft between the two domains (Figure 4.1 
B).  Domain I serves as the pyridoxal binding domain and Domain II as the phosphate 
binding domain.  PLP is anchored in the active site via the imine formed between the 
4´-aldehyde group and the N6-amine group of Lys62, with His66 stacked on top of it 
(5).  The distance between the pyridine ring and the histidine imidazole ring is within 
the van der Waals distance (~4 Å), thus unveiling the identity of the catalytic histidine 
residue (Figure 4.2 A). The 3-hydroxyl group of PLP forms hydrogen bond with 
Asn11 located in the loop region between β1 and η1.  Below the pyridine ring, Trp12 
is positioned in parallel to form π-π interactions, thereby further stabilizing the 
pyridine ring.  In the phosphate binding site, phosphate binding takes place through H-
bonds to the backbone amides of Gly115, Glu116, Phe117 and Gly118.  These 
residues form the N-terminus of a long α-helix and the helix-dipole is positioned to 
stabilize phosphate binding.  At the other side of the active site, Cys199 is about 5 Å 
away from the pyridoxal ring (Figure 4.2 B), bridging the active site to a cysteine-rich 
motif, CCCFC (residue 194-199).  The cysteines are located in η6 that are tightly 
constrained between α9 and β10.  While the sulfhydryl of Cys199 points towards PLP, 
sulfhydryls of Cys195 and Cys197 pointed towards each other, with a distance of 3.0 
Å.  This distance is a bit longer than an average disulfide bond distance of 2.3 Å, 
indicating a mixture of disulfide and thiol.  Cys196 points away from Cys195 and 
Cys197, towards a salt bridge formed by Asp188 and Arg186.  Despite the fact that 
cysteine-rich motif is often involved in [Fe-S] cluster binding, no evidence of [Fe-S] 
cluster has been found in THI5p (results not shown).  Nevertheless, the protein activity 
towards the binding of mono iron has been confirmed (5), although no convincing 
electron density for iron has be identified in the structure.  Considering the close 
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proximity of Cys199 to PLP, the CCCFC motif could be potentially involved in iron-
mediated electron transfer and radical reactions (7). 
 
Figure 4.2.  Active site of THI5p/PLP complex.  (A) Stereoview of the active site 
residues of THI5p complexed with covalently bound PLP.  Active site residues within 
van der Waals radii of the PLP molecules are shown.  Hydrogen bonds formed 
between PLP and amino acid side chains are represented by black dashes. (B) 
Stereoview of the CCCFC motif in proximity to the PLP binding site.  Protein atoms 
are colored grey and ligand atoms are colored yellow.    
The Structure of Modified-THI5p.  After incubating THI5p with 
Fe(NH4)2(SO4)2 and PLP, tetragonal bipyramidal shaped crystals appeared after five 
months.  Instead of the orthorhombic space group P212121 as the THI5p/PLP complex, 
the modified-THI5p was crystallized in tetragonal space group P43212, in a higher 
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symmetry.  The crystal packing became tighter and involved more protein-protein 
contacts while retaining the same dimer interface. 
In each protomer, Domain I maintains the same geometry as the pre-reaction 
complex, whereas Domain II undergoes significant conformational changes (Figure 
4.3) according to Difference Distance Matrix Analysis (20).  Contrary to the hinge- 
Figure 4.3.  Difference Distance Matrix Analysis of THI5p/PLP complex (X-axis) vs. 
modified-THI5p (Y-axis).   
bending motion that has been observed in Domain II (equivalent to the phosphate 
binding domain) of Type II PBPs that undergo a 50° rotation and a negligible 
transition (21) or twist (22), the secondary structure in THI5p is mostly engaged in 
local movements (Figure 4.5 A).   Starting from the two crossovers, η6 and the loop 
between β4 and β5 change the conformation substantially.  The backbone of helix-η6 
stretches out, connects to the backbone of residues 86-88 through hydrogen bonds and 
forms an anti-parallel β-sheet.  Notably, η6 corresponds to residue 196-199, wherein 
the CCCFC motif is.  The three-dimensional arrangement of the CCCFC motif alters 
dramatically.  Instead of having Cys195 and Cys197 pointing into each other, a 
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disulfide bridge forms between Cys195 and Cys196.  The flanking helix containing 
residues 187-191 also unwinds and becomes part of the loop connecting α9 and η6.  
The loop rotates for about 40° and the movement propagates to α9 and β9, involving 
the displacement of the central pleated β-sheet for about 2 Å.   
On the other side of Domain II, a small loop between β6 and α6 shifts in for 
about 2.5 Å.  This region corresponds to the phosphate binding site, where residues 
115-118 are located and interact with PLP through backbone hydrogen bonding to the 
phosphate group.  In addition, the electron density between surface residues 176 and 
182 is missing, corresponding to the 310-helix η5 in the THI5p/PLP complex.   
Although no ligand has been found in the active site, it does not seem to be 
simply an apo form of the protein due to several difference densities shown in the 
structure.  The density for the Cys199 side chain is significantly larger than a normal 
thiol group (Figure 4.4 A).  When the cysteine was modeled in, difference density 
showed up at three corners.  Instead of the globular-shaped density of a normal 
sulfhydryl group, the density looks more planar, resembling a triangle from the top 
down view (Figure 4.4 B), with one dimension slightly longer than the other.  
Combined with the LC-MS data (Figure 4.6), the map indicates the formation of 
sulfonic acid. 
Besides the altered cysteine density, another two regions remain curious.  But 
due to the poor map quality of some residues, it can be hard to interpret.  One is the 
negative density on His66, which was initially modeled in as histidine.  The negative 
difference density covers half of the imidazole ring at the contour level of 3.0 σ.  In 
the composite omit map, the histidine contains the density for only half the ring, 
missing the N==C—N corner of imidazole (Figure 4.4 C, D).  The other piece of 
puzzle involves an unknown density on the surface of the protein, connecting the side 
chains of Cys162 and Cys197 (Figure 4.4E).   The spatial distance between the two 
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cysteine residues is 13 Å.  The unknown density links the cysteine side chains through 
the sulfhydryl group.   
 
Figure 4.4.  Composite omit map for residues in modified-THI5p.  The map is 
contoured at 1σ.  (A) Electron density corresponding to a normal cysteine residue, 
Cys260, in the modified-THI5p.  (B) Electron density corresponding to the modified 
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cysteine residue, Cys199, with the thiol group replaced by sulfonic acid.  (C) Electron 
density corresponding to a normal histidine residue, His18.  (D) Electron density 
corresponding to His66.  (E) Electron density between the side chains of Cys162 and 
Cys197. 
Figure 4.5.  The structural comparisons of THI5p/PLP complex (yellow) with (A) the 
modified-THI5p (purple), (B) the C199A/PLP complex (19), (C) the E309Ter/PLP 
complex (pink), and (D) the THIYp/FAMP complex (blue). 
The Structure of C199A/PLP.  Following the same procedure as for the 
modified-THI5p protein, the C199A mutant was cocrystallized with Fe(NH4)2(SO4)2 
and PLP and yellow crystals were obtained.  One molecule of PLP was observed in 
the active site for each protomer, retaining the same active site geometry as the native 
protein (Figure 4.5 B).  The reaction did not proceed in spite of the addition of 
Fe(NH4)2(SO4)2 and PLP.  The overall structure of C199A/PLP complex is very 
similar to the THI5p/PLP complex, with the RMSD of only 0.2 Å, in contrast to 2 Å 
between the THI5p/PLP complex and the modified-THI5p.  The only major difference 
occurs at the C-terminus.  In contrast to the missing density for the C-terminus of the 
native protein, C199A shows the full length protein with an α-helix at the C-terminus.  
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Contrary to the overall B-factor of 16.5 Å2 for all atoms, the C-terminal 32 residues 
have the average B-factor of 29.9 Å2, which is almost twice as much as the rest of the 
protein, reflecting the flexibility of the C-terminus.  Besides the difference at the C-
terminus, the distance between the two Sγ of Cys195 and Cys197 (4.0 Å) is much 
longer than that of the THI5p/PLP complex (2.8 Å).   
E309Ter mutant.  In order to assess if the presence or absence of the flexible 
C-terminus can affect the overall structure, E309Ter, the C-terminus truncated version 
of THI5p was cocrystallized with Fe(NH4)2(SO4)2 and PLP, according to the same 
procedure as the C199A/PLP complex.  The protein was crystallized in the space 
group of P22121, different from the THI5p/PLP complex.  Given the altered crystal 
packing, the active site also has a PLP molecule bound and the overall dimeric 
structure is very close to THI5p/PLP complex, with the RMSD of only 0.3 Å (Figure 
4.5 C).  This further implies that the C-terminus does not affect the overall 
conformation of THI5p. 
Detection of Modified Cys199 by Mass Spectrometry.  The site of Cys199 
modification was also identified by LC-MS analysis of THI5p following trypsin 
digestion (Figure 4.6).  Trypsin cleaves after lysine and arginine residues.  Without 
adding Fe(NH4)2(SO4)2, trypsin digestion yields a peptide detected by LC-MS, 
corresponding to the sequence of LAELGCCCFCTILYIANDK (Mass=2320.54 Da, 
amino acids 190-208), with four cysteine side chains carbamidomethylated by 
iodoacetamide.  With the addition of Fe(NH4)2(SO4)2, the molecular weight of the 
peptide changed to 2311.50 Da, consistent with the modification of three 
carbamidomethylation and one trioxidation.  The absence of one 
carbamidomethylation and the addition of trioxidation indicated that one of the 
cysteine residues was unable to be carbamidomethylated, whereas one residue was 
trioxidized.  These two concurrent events indicated that the missing 
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carbamidomethylation and the oxidation might have occurred to the same cysteine 
residue.  In contrast, when Fe(NH4)2(SO4)2 were added to the C199A mutant, the LC-
MS analysis showed that C199A had only three carbamidomethylations 
(Mass=2232.05 Da).  This thereby implied that Cys199 was the site of trioxidation 
modification since the C199A mutant was unable to undergo trioxidation. 
Figure 4.6.  Analysis of Cys199 by LC-MS.  (A) LC-MS data of a peptide from 
trypsin digestion of apo THI5p containing the CCCFC motif.  The observed 2320.54 
Da corresponds to the sequence of LAELGCCCFCTILYIANDK (amino acids 190-
208).  (B) The observed mass of the peptide shifts to 2311.50 with the addition of iron 
in THI5p.  (C) The observed mass of the peptide shifts to 2232.05 Da with the 
addition of iron in C199A.  
Section 4.4. Discussions 
THI5p and Periplasmic Binding Proteins.  PBPs, together with the ATP-
binding cassette transport systems, are involved in the active transport of small 
 87 
molecules and ions (23).  Despite the large sequence variance, PBPs share common 
features in the three-dimensional structure.  PBPs generally consist of two globular 
domains with α/β fold, bisected by a cleft wherein the ligand is buried.  The binding of 
the ligand frequently involves a hinge-binding motion between the two domains (24).   
According to the topological arrangement, PBPs can be classified into three 
types by the number of inter-domain connections:  Type I has three crossovers, Type 
II has two and Type III has one (15, 25).  While little is known about the topology of 
the Type III PBPs, structures of Type I and Type II have been extensively studied.   
Both domains in the Type I PBPs have the topology of β2β1β3β4β5.  In contrary, Type 
II PBPs has the topology of β2β1β3βnβ4.in both domains, in which βn stands for the 
strand immediately after the crossover from the other domain.   
In the case of THI5p, Domain I has the topology of β2β1β3β10β4 and Domain II 
of β7β6β8β5β9, wherein β10 and β5 are the strands right after the crossover in their 
respective domain.  Therefore, THI5p belongs to Type II PBPs.  Since the lysine-PLP 
adduct is positioned in the groove between the two domains, the ligand binding pattern 
of THI5p is also consistent with the characteristics of Type II PBPs.  
However, in spite of the significant conformational change in the course of 
ligand binding and release in THI5p, its conformational change differs from the hinge-
bending motion of other PBPs.  Upon the ligand binding, Domain I retains the same 
position, whereas Domain II rotates for about 50° (21), closing around the bound 
ligand through a Venus flytrap mechanism (26).  Although THI5p also has Domain I 
anchored, and Domain II going through a series of conformational changes, the 
movements in Domain II are primarily alterations of secondary structures and local 
rotations and translations.  
Comparison with other Structures.  DALI search (27) results showed that the 
FAMP-binding protein THIYp (PDB code 3IX1) (8) has the highest structural 
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similarity to THI5p, with the Z score of 33.6 and RMSD of 2.3 Å.  Other structural 
homologs include possible thiamin biosynthesis enzyme (PDB code 2X7P, 2X7Q) 
(28), alkane sulfonate-binding protein SsuA (PDB code 3KSJ, 3KSX, 3E4R and 
2X26) (29), periplasmic nitrate-binding protein NrtA (PDB code 2G29) (30) and 
biocarbonate transport protein CmpA (PDB code 2I48, 2I49, 2I46 and 2I4C) (31).  All 
of these proteins are dimeric periplasmic binding proteins and serve different roles in 
small molecule transport through membranes.  
Although THIYp and THI5p both contain a dimer per asymmetric unit, the 
packing interfaces are quite different.  The THIYp dimer interface consists of β6, β7, 
α10 and the loops between α6 and β8 (8), while the interface in THI5p is composed of 
β1, β2, η2, α7, α10, α13 and the loop connecting α4 and β4.  When superimposing one 
protomer of THI5p on THIYp, the other protomer of THI5p will be at almost a 180° 
rotation from that of THIYp.  Despite distinct protomer arrangements, the tertiary 
structures of THI5p and THIYp are very close, with RMSD of 2.3 Å.  In the structure 
of THIYp complexed with FAMP, a thiamin salvage pathway intermediate and a HMP 
homolog, FAMP is buried in the active site and makes extensive stacking and 
hydrogen bonding interactions with the environment (8).  The superposition of THIYp 
and THI5p structures shows that the backbone traces of the two structures align well 
and the ligand binding site are in close proximity (Figure 5D).  The distance between 
the FAMP pyrimidine ring in THIYp and the PLP pyridoxal ring in THI5p is about 5.5 
Å.  FAMP is stacked on top of Trp39 in THIYp, which corresponds to Trp12 in 
THI5p.  Due to the structural similarity between FAMP and HMP-P, the product of 
THI5p, the binding position of FAMP could therefore imply a putative binding site for 
HMP-P in THI5p (Figure 4.7). 
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Figure 4.7.  Active site of THI5p with PLP removed, and FAMP modeled in based on 
the superposition of the structures of THI5p/PLP and THIYp/FAMP.  The ribbon 
diagram of THI5p is colored green.  The conserved residues shared by both THI5p and 
THIYp are colored purple.  The rest of residues in the THI5p active site are colored 
grey.  The ligand FAMP is colored blue.  
The Modified Cysteine Side chain.  In the structure of modified-THI5p, apart 
from the conformational changes, an unusual density was observed in the side chain of 
Cys199.  Cys199 was the last cysteine residue in the CCCFC motif and was absolutely 
conserved among all THI5p homologs.  The side chain of Cys199 showed a much 
larger electron density than a normal thiol group. This observation was further 
explained by LC-MS analysis on the peptide containing the CCCFC motif, in which 
Cys199 was identified as the site for trioxidation into sulfonic acid and thereby was 
unable to be carbamidomethylated.  The electron density for the modified thiol is also 
consistent with a sulfonic acid.  The triangular shaped head of the modified thiol group 
has one dimension slightly longer than the other, representing the hydroxyl group.    
The oxidation on cysteine has been identified in various oxidation states in 
proteins.  Due to the interdependency of the catalytic activity and the wide variety of 
redox chemistry, many cysteine proteins are considered as "redox switches" to sense 
the concentration of oxidative stressors (32).  Cysteine-rich proteins also participate in 
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the signaling pathways involving proteins such as apoptosis signal-regulated kinase 1 
(33, 34), bacterial transcription factor OxyR (35) and protein tyrosine phosphatases 
(36).   Among all the oxidation and reduction reactions, the most common oxidation 
states for cysteine are the thiol and disulfide. The conversion from thiol to disulfide is 
reversible in various proteins such as thioredoxin reductase (37) and human 
glutathione disulfide reductase (38) simply through the two electron transfer from 
FADH2.  But the oxidations of thiol into sulfenic acid, sulfinic acid and sulfonic acid 
cannot be reversed as easily as the disulfide formation (32, 39, 40).  Hydrogen 
peroxide and other biological oxidants such as peroxynitrite can oxidize thiol or 
thiolate anion into sulfenic acids (41).  Although this process is also reversible, the 
electrophilic sulfur atom in sulfenic acid needs to carry out a condensation reaction 
with a nearby cysteine thiol in the protein or a low-molecular weight thiol such as 
glutathione to form disulfide, prior to further reduction into thiol (42).  Unstable and 
highly reactive sulfenic acid can be readily oxidized into sulfinic acid and sulfonic 
acid.  Sulfinylation was considered irreversible until the discovery of sulfiredoxin, an 
ATP-dependent enzymatic sulfinic acid reductase (43), which specifically reduces the 
sulfinic acid (44) in the peroxiredoxin (45).  The sulfonylation, however, is 
irreversible, and the oxidized protein is frequently subjected to ubiquitinaiton and 
degradation, such as in the case of GTPase-activating proteins (46).   
In terms of protein function, on one hand, oxidation of the key reactive 
cysteine thiols can inhibit the function of the redox-sensitive proteins such as 
glyceraldehyde-3-phosphate dehydrogenase and tyrosine phosphatase (47).  On the 
other hand, oxidation can activate the protein in terms of the chaperone function, like 
in the case of sulfenylation of Hsp33 (48) and sulfonylation of peroxiredoxin (45).  
Furthermore, oxidation of cysteine thiol groups into sulfenic acid and sulfinit acid can 
assist the metal binding, as the example shown in cobalt-containing nitrile reductase 
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(49, 50).  Although the detailed process of sulfonylation in THI5p has not been 
revealed, the sulfonylation in peroxiredoxin has been shown not to be a process of 
auto-oxidation studied both in vitro and in vivo (45).  Moreover, oxidation from 
sulfinic acid to sulfonic acid in peroxiredoxin has been proved to significantly enhance 
the chaperone activity from both biochemical data and microscopic imaging, which 
provides further insights into the enzyme functional change after the irreversible 
oxidation (45).   
Despite of the intriguing chemistry that the irreversible oxidation of thiol 
implies, we cannot rule out the possibility that the modified cysteine could be an 
artifact during protein crystallization and the pre-treatment for mass spectrometry 
analysis.  In order to further explore the role of cysteine residues and their structural 
and functional relationship to the iron binding site, UV-Vis, Mössbauer (19), electron 
paramagnetic resonance (51) and X-ray absorption spectroscopy (52) can be used to 
elucidate the coordination and oxidation states of iron.  Although the type of 
modification has not been fully determined, all the structural and biochemical 
evidence indicate that this cysteine residue is highly reactive and can be actively 
engaged in the reaction. 
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CHAPTER 5 
CONCLUSION 
The work presented here encompasses a wide range  of biological problems in 
terms of protein structure and function.  X-ray crystallography coupled with 
biochemical analysis provides valuable insights into the molecular mechanism of 
enzyme catalysis.  The snapshots captured along the reaction coordinate not only 
outline the whole picture of the reaction process, but also reveal subtle changes in the 
structure that catalyzes the chemistry of life.  The structural characterization in various 
metabolic pathways also enables the rational drug design based on the understanding 
of the catalytic mechanisms. 
The structural characterization and mechanistic study on ΨMP glycosidase in 
Chapter 2 represents a scenario in which structural information becomes essential 
when multiple mechanisms appear plausible.  As the most abundant modification in 
RNA, Ψ is post-transcriptionally isomerized by Ψ synthase through the cleavage of 
glycosidic C-N bond, which reconnects the uracil to the ribosyl moiety.  Since the 
mechanism of modification of uridine into Ψ has been extensively studied (1), the 
microscopic reverse of this process thereby stands for one possibility of the Ψ 
degradation reaction.  Similar to the extensively studied N- and O- glycosidic bond 
cleavage (2-8), this process involves an oxocarbenium ion intermediate through a 
largely dissociative mechanism.  Nevertheless, a novel mechanism emerges after 
several structures of substrate and intermediate complexes of ΨMP glycosidase are 
determined.  A lysine residue is observed to form covalent adduct with the ring-
opened ribose ΨMP.  Such adduct releases the uracil while retaining the covalent 
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linkage between the lysine and a ring-opened R5P.  LC-MS analysis and site-directed 
mutagenesis establishes further evidence for the covalent adducts, indicating a novel 
ribose ring-opening mechanism.   Although an alternative mechanism in which the 
lysine displaces the pyrimidine from the ribose can be found in other enzymes, the 
lysine residue modeled in ΨMP glycosidase is not positioned for direct base 
displacement, and the ring-opened ribose ΨMP complex is not consistent with this 
mechanism.   In all, the four unique crystal structures suggest that the reaction utilizes 
Lys166 to form a covalent adduct to overcome the energy barrier and facilitate the 
cleavage of the thermodynamically stable C-C glycosidic bond.  The crystal structures, 
in conjugation with mass spectrometry and kinetic analysis demonstrate that ΨMP 
glycosidase catalyzes the cleavage of the C-C glycosidic bond through a novel ribose 
ring-opening mechanism.   
Another scenario in which protein structure plays a critical role in elucidating 
the mechanism is represented in the structure determination of eukaryotic thiamin 
pyrimidine synthase.  Thiamin biosynthesis generally involves the separate formation 
of the thiazole and pyrimidine moieties, which are then condensed to form the thiamin 
pyrophosphate.  In prokaryotes, the enzymes involved in the biosynthetic pathway of 
thiamin have been extensively studied (9).  In eukaryotes, while the formation of the 
thiazole ring has been recently characterized structurally and biochemically (10), little 
is know about the mechanistic details for the pyrimidine synthesis.  The mechanism of 
pyrimidine synthesis thus remains the last piece of puzzle to complete our 
understanding of the de novo biosynthetic pathway of thiamin across all organisms 
(11).  Chapter 3 demonstrates the first mechanistic and structural study of THI5p.  
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Labeling studies and LC-MS analysis have shown that the HMP-P formation utilizes 
PLP and a histidine residue from the THI5 protein.  In C. albicans, THI5p contains six 
histidine residues, two of which are absolutely conserved among all species.  
Paradoxically, mutation of any of the two histidine residues abolishes the enzyme 
activity according to the kinetic assays.  Therefore, the histidine residue that serves as 
the donor for HMP-P formation is unable to be identified with only biochemical 
analysis.  Not until the crystal structure was solved, has the identity of the key 
histidine residue been revealed.  The structure of THI5p complex with PLP shows 
His66 stacked on top of PLP, which is bound via an imine formed with an active site 
lysine.  Together, the biochemical assay and the crystal structure suggest that His66 of 
the THI5 protein is the histidine source for pyrimidine formation and the pyrimidine 
synthase is a single-turnover enzyme.  In Chapter 4, further insights are provided for 
the THI5p after running the reaction with PLP and iron.  Unusual difference density is 
observed for Cys199 as part of the CCCFC motif.  The trigonal-shaped large electron 
density on the cysteine side chain indicates a sulfonic group, which is consistent with 
the LC-MS result.  The modified-THI5p also undergoes significant conformational 
changes in the phosphate binding domain.  Given that THI5p belongs to Type II PBPs 
according to topological arrangement, the conformational change of the modified 
THI5p differs from the hinge-binding motion for other PBPs upon the binding and 
releasing of the ligand.  Distinct from the Venus fly trap mechanism as previously 
proposed (11),  the conformational changes of THI5p involve local movement of the 
secondary structures throughout the domain.  In addition to the modified-THI5p, the 
structure of C199A/PLP is determined, with high structural similarity to the native 
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protein.  Given both PLP and iron are added to run the reaction during protein 
purification, the crystal structure shows that the reaction does not proceed and only 
PLP is bound as in the THI5p/PLP complex.  Determined at high resolution, the 
C199A/PLP shows the previously undetermined C-terminal as an α-helix followed by 
a loop, with high flexibility indicated by the B-factor.  The C-terminal residues cover 
on top of the CCCFC motif, which is proposed to be the iron binding site.  The spatial 
proximity can thus enable the C-terminal residues to modulate the dielectric constant 
around the iron.  In order to further investigate the effect of the flexible C-terminus, 
we mutated THI5p into a C-terminus truncated THI5p, E309Ter.  Given similar 
treatment to the modified-THI5p, with iron and PLP, the structure of E309Ter closely 
resembles that of the THI5p/PLP complex, in which only PLP is bound and no 
reaction observed.  The structure similarity between E309Ter/PLP and THI5p/PLP 
implies that the C-terminus does not affect the overall structure of the protein, but 
could be potentially involved in the iron binding.   
Each of the structure above represents the functional and mechanistic insights 
that structural biology has brought us to the understanding of life science.   The 
structure of ΨMP glycosidase reveals, for the first time, the mechanism of the C-C 
glycosidic bond cleavage in nature.   The structure of THI5p demonstrates its distinct 
character as a suicide enzyme and has intrigued active research in the mechanistic 
details of the complicated chemistry.  Given the tremendous effort to elucidate the 
structural details of these proteins, more fascinating research and collaborations are 
going on across the field of biology, chemistry and physics in this new era of structure 
biology. 
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